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ABSTRACT 
 
Epigenetic Regulation of Embryonic and Intestinal Stem Cells  
by DNA hydroxymethylation  
 
Rinho Kim 
Dr. Klaus H. Kaestner 
 
DNA methylation at the 5 position of cytosine is a well-characterized epigenetic 
modification that is important for essential cellular processes including stem cell 
proliferation and differentiation. 5-methylcytosine (5mC) can be oxidized by the Ten 
Eleven Translocation (TET) family of enzymes to 5-hydroxymethylcytosine (5hmC), 
which has been suggested as either an intermediate in DNA demethylation or as an 
independent epigenetic modification that directly regulates gene expression. Gene 
silencing and activation are important processes in embryonic stem cells (ESCs) and 
intestinal stem cells (ISCs) for their self-renewal and differentiation, but our 
understanding of the potential role of 5hmC and TET hydroxylases in these processes is 
still limited.  
Here, I generate genome-wide maps of the 5hmC mark in ISCs and their 
differentiated progeny and utilize Tet1-/- mice model to investigate the role of TET1 in 
the intestinal epithelium. Genes with high levels of hydroxymethylation in ISCs are 
strongly enriched for developmental regulation functions. The Tet1-deficient postnatal 
intestine shows significantly reduced numbers of proliferative cells and decreased Wnt 
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target genes expression, which correlates with lower 5hmC levels at their promoters. 
These data demonstrate that Tet1-mediated DNA hydroxymethylation is important for the 
self-renewal of the intestinal epithelium.  
To determine a novel role of 5hmC, we perform integrative analyses of various 
epigenomic sequencing datasets, and identify a group of distal transcription factor 
binding sites as putative silenced enhancers, which are lacking active histone marks and 
nascent transcription, but are nevertheless highly enriched for the 5hmC modification in 
ESCs. During lineage specification of ESCs, these silenced elements lose 5hmC and 
acquire the H3K4me1/2 histone marks and become active. I demonstrate that these 
elements function as enhancers when the 5hmC mark is removed by a reporter assays. 
These data suggest that 5hmC suppresses the activity of a specific subset of enhancers in 
ESCs.  
In summary, DNA hydroxymethylation contributes to both transcriptional 
activation and repression for epigenetic gene regulation in stem cells.  
  
	  v	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CHAPTER 1 
	  
	  
	  
	  
	  
Introduction 
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1.1 Development and structure of the intestinal epithelium 
	  
The intestine is a simple tubular organ that connects the stomach to the anus, and 
is essential for the absorption of nutrients and water. In mice, the gastrointestinal tract 
originates from the endoderm at embryonic day (E) 7.5, and is regionalized along the 
anterior-posterior axis into foregut, midgut and hindgut, guided by epithelial-
mesenchymal interactions at E 8.5 (Figure 1.1). The small intestine and colon are 
developed from the midgut and hindgut, respectively, while the foregut gives rise to the 
esophagus and stomach, as well as the gut-associated organs thyroid, ling, liver, and 
pancreas (Zorn and Wells, 2009). 
 
Figure 1.1 Development of the intestine. (Left) The major events during endoderm 
organ formation between E 7.5 to 9.5. (Right) Endoderm cell lineages of the 
gastrointestinal tract. Adapted from (Zorn and Wells, 2009). 
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The intestinal epithelium is structured as a pseudostratified epithelium until E 
13.5 (Figure 1.2). After this point, mesenchymal clusters appear around epithelial cells, 
which secrete hedgehog (Hh) and platelet-derived growth factor A (Pdgfa), and drive 
villus morphogenesis at E 14.5 (Figure 1.2; (Karlsson et al., 2000; Madison et al., 2005; 
Walton et al., 2012)). During villus morphogenesis, the pseudostratified epithelium is 
transformed into a columnar epithelium with stereotypical villi that project into the 
lumen, and proliferative intervillus regions. The intervillus epithelium is reshaped to 
develop crypts in the first week after birth in mice. The maturation of villus and crypt 
continues until the weaning age, when mice are approximately 3-4 weeks old (Wells and 
Spence, 2014). During human development, villus and crypt development occur 
prenatally. 
 
Figure 1.2 Villus and crypt formation. At E 14.5, mesenchymal clusters (orange) is 
required for villus morphogenesis. As the epithelium remodels between E 14.5 to 16.5, 
the fetal intestinal epithelium consist of villus (green) and proliferative intervillus 
(yellow) regions. The mature adult crypt contains the intestinal stem cells (yellow) and 
secretory Paneth cells (red), as well as several additional cell types, such as enterocytes 
(green), goblet cells (blue) and enteroendocrine cells (purple). Adapted from (Wells and 
Spence, 2014). 
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The mature small intestinal epithelium is composed of a single layer of cells that 
contains stem, transit-amplifying and four different lineages of differentiated cells, such 
as enterocytes, goblet cells, enteroendocrine cells and Paneth cells (Figure 1.2; (Cheng 
and Leblond, 1974b)). Enterocytes are absorptive cells, which have a brush border on 
their apical surface and also secrete hydrolytic enzymes essential for the digestion of 
food. Goblet cells secrete mucus, which lubricates and protects the intestinal wall from 
liminal contents. Enteroendocrine cells are rare and secrete various hormones such as 
peptides and catecholamines. Paneth cells reside at the bottom of the crypt and secrete 
antibacterial proteins such as lyzosomes and defensins in the small intestine, but not the 
colon.  
The intestinal epithelium is the most rapidly renewing tissue in human body. This 
renewal process takes only five days to complete and is fueled by intestinal stem cells 
(Heath, 1996; Potten and Loeffler, 1990). Intestinal stem cells reside at the crypt base and 
give rise to rapid-cycling transit-amplifying cells that differentiate into mature epithelial 
cells migrating up along the crypt-villus axis, and that are shed at the top of the villi. 
Only Paneth cells move downward to the bottom of the crypt and have a longer life span 
of 6-8 weeks. Rapid renewal and distinctive morphology make the intestinal epithelium 
an excellent model to study the mechanisms underlying cell proliferation and 
differentiation in adult tissues. To maintain normal function of the intestinal epithelium, 
precise regulation of cell proliferation and differentiation is essential (Crosnier et al., 
2006). 
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1.2 Wnt signaling in intestinal development and homeostasis  
	  
Wnt signaling is involved in many aspects of embryonic development and adult 
tissue homeostasis, and the signaling molecules are highly conserved across metazoans 
(van Amerongen and Nusse, 2009). The canonical Wnt pathway relies on β-catenin as its 
key effector. In the absence of a Wnt signal, cytosolic β-catenin (β-cat) is maintained at a 
minimum by the 'destruction complex composed of ademomatous polyposis coli (APC), 
Axin, glycogen synthase kinase 3 β (GSK3β) and Disheveled (Dvl)’ (Figure 1.3; (Logan 
and Nusse, 2004)). Wnt signaling is activated by binding of secreted Wnt ligands to the 
transmembrane Frizzled sreceptor and the low-density lipoprotein receptor protein (LRP) 
that mediate downstream Wnt signaling (Figure 1.3; (Bhanot et al., 1996; Pinson et al., 
2000)). Binding of R-spondins (R-spo) to leucine-rich repeat-containing G-protein 
coupled receptor (Lgr) 4/5/6 receptor stabilizes Frizzled to potentiate Wnt signaling 
(Figure 1.3; (Carmon et al., 2012; de Lau et al., 2011)). Activation of the Wnt pathway 
leads to destabilization of the destruction complex and translocation of β-catenin. Nuclear 
β-catenin interacts with DNA-binding proteins termed somewhat misleadingly 'T-cell 
factor/lymphoid enhancer-binding factor (TCF/LEF)' to regulate transcription of context-
specific Wnt target genes (Figure 1.3; (Clevers and van de Wetering, 1997; Logan and 
Nusse, 2004)).  
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Figure 1.3 Wnt signaling pathway. (Left) In the absence of Wnt ligand, the destruction 
complex containing APC, Axin, GSK3β, and Dvl phosphorylates β-cat and leads its 
degradation in the cytoplasm. In the nucleus, TCF/LEF is inactive and Wnt target genes 
are “OFF”. (Right) Upon binding of Wnt ligand to the Frizzled and the LRP with binding 
of R-spo to Lgr for enhancing signals, the destruction complex is disintegrated. 
Accumulated β-cat could translocate into the nucleus and interact with TCF/LEF 
transcription factor to upgegulate Wnt targe genes “ON”. Adapted from (Jansson et al., 
2015). 
 
 Wnt signaling regulates multiple aspects of embryonic intestinal development and 
adult intestinal homeostasis. During embryonic development, β-catenin is known as an 
essential factor for endoderm formation (Imai et al., 2000; Lickert et al., 2002) In mice, 
Wnt signaling is active at E 7.5 in the posterior endoderm and transiently induces caudal-
related homeobox 2 (Cdx2), the master regulator of intestinal development (Gao et al., 
2009; Sherwood et al., 2011). Until E 14.5, the Tcf4-deficient intestine shows no 
noticeable difference in the tissue organization and cell proliferation. However, at E 16.5 
and afterward, a reduced number of villi and loss of proliferating cells in intervillus 
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regions are observed in the small intestine of the mutant mice, leading to neonatal 
lethality (Korinek et al., 1998). In addition, canonical Wnt signaling is active in 
intervillus regions after birth, suggesting that Wnt signaling may play an important role in 
de novo crypt formation and crypt fission in mice (Kim et al., 2007). 
 The Wnt pathway is the master regulator of intestinal epithelial regeneration in 
the adult. Active Wnt signaling in intestinal crypt is a major driving force for intestinal 
stem cell renewal and proliferation of transit-amplifying (TA) cells. Tight regulation of 
Wnt signaling is critical for the intestinal epithelial homeostasis (Gregorieff and Clevers, 
2005). Reduced Wnt signaling results in loss of crypt regenerative capacity. 
Overexpression of the Wnt antagonist Dickkopf1 in adult transgenic mice or intestinal 
epithelial-specific deletion of β-catenin leads to reduced proliferation, loss of crypts and 
reduced numbers of secretory cells (Ireland et al., 2004; Pinto et al., 2003). Recently, 
ablation of Wnt-secreting Forkhead box L1+ (Foxl1+) intestinal mesenchymal cells or 
deletion of the Wntless gene, which is required for the secretion of Wnts, in adult mice, 
was shown to cause loss of intestinal stem cells and impairment of intestinal homeostasis 
(Figure 1.4; (Aoki et al., 2016; Valenta et al., 2016)). In contrast, aberrant activation of 
Wnt signaling leads to intestinal neoplasia. For instance, deletion of Apc in Lgr5+ 
intestinal stem cells results in constitutively active Wnt signaling and leads to widespread 
transformation (Barker et al., 2009).  
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Figure 1.4 Wnt signaling in intestinal homeostasis. (Left) Intestinal homeostasis is 
maintained in normal condition. Wnts are secreated from Paneth cells and mesenchymal 
cells. (Middle and Right) Wnts secretion is globally blocked by deletion of Wntless gene. 
(Middle) Loss of intestinal stem and TA cells without Wnt signaling. (Right) Intestinal 
stem and TA cells are survived with exogenous reconstitution of Wnt3a or Wnt2b. 
Adapted from (Valenta et al., 2016). 
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1.3 Intestinal stem cells and organoids 
	  
 Two intestinal stem cell compartments have been reported in the literature: the '+4 
cell' model and the 'crypt base columnar cell' model. +4 cells reside immediately above 
the Paneth cells in the ‘+4’ position when counted from the crypt base. This was a 
population characterized by slow cycling and long term retention of a label incorporated 
into DNA during S-phase, and proposed to be the intestinal stem cell (Potten et al., 1974). 
Many studies identify various +4 stem cell markers including Bmi1, homeodomain-only 
(Hopx), telomerase reverse transcriptase (Tert) and Leu-rich repeats and 
immunoglobulin-like domains 1 (Lrig1), which were confirmed by genetic lineage 
tracing to contribute to all differentiated epithelial cell lineages. (Figure 1.5; 
(Montgomery et al., 2011; Powell et al., 2012; Sangiorgi and Capecchi, 2008; Takeda et 
al., 2011)). The situation might be even more complex, as it was suggested recently that 
+4 cells marked by Hopx/Bmi1-CreER are non-overlapping with the +4 label retaining 
cells (Li et al., 2016). 
 Crypt base columnar (CBC) cells are located at the crypt base and intermingled 
with Paneth cells (Cheng and Leblond, 1974a). Recently, several markers of CBC cells 
have been identified, such as Lgr5, Musashi homologue 1 (Msi1), olfactomedin 4 (Olfm4) 
and Achaete–Scute homologue 2 (Ascl2). These cells were confirmed by genetic lineage 
tracing and in vitro culture as actively dividing stem cells (Figure 1.5; (Barker et al., 
2007; He et al., 2007; Sato et al., 2009; van der Flier et al., 2009a; van der Flier et al., 
2009b)).  
	  10	  
 
Figure 1.5 Intestinal stem cells: +4 and CBC stem cells. Summary of intestinal stem 
cell pools with their markers. +4 stem cells are located the fourth position from the crypt 
bottom. They are relatively quiescent, resistant to acute damage and retain DNA labels. 
CBC stem cells are intermingled with Paneth cells. They are highly proliferative and 
sensitive to damage. Adapted from (Barker, 2014). 
 
 Interestingly, proliferative CBC stem cells are dispensable for intestinal epithelial 
homeostasis, as quiescent +4 stem cells are activated when CBCs are ablated. Thu upon 
deletion of Lgr5+ stem cells by genetic ablation or radiation, Bmi1+ stem cells actively 
give rise to Lgr5+ stem cells to rapidly recover the entire intestinal epithelial cell sheet 
(Tian et al., 2011; Yan et al., 2012). Conversely, Lgr5+ stem cells can also give rise to 
Bmi1+ stem cells in intestinal organoids in vitro (Takeda et al., 2011). 
Precursor/progenitor cells of the intestinal epithelium also show their cellular 
dedifferentiation capacity (Figure 1.6). Absorptive progenitor cells expressing alkaline 
phosphatase around position +6 upward and secretory progenitor cells expressing the 
Notch ligand Dll1 in the +4 position can dedifferentiate into stem cells in vivo to 
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regenerate entire crypt-villus units upon stem cell loss (Tetteh et al., 2016; van Es et al., 
2012b). A quiescent label-retaining cell (LRC) population around the +4 position serves 
as Paneth and enteroendocrine cells precursor, and does not contribute to the stem cell 
pool during homeostasis. However, a subset of this population expresses Lgr5 and +4 cell 
markers and gives rise to proliferative intestinal stem cells under conditions of cytotoxic 
damage (Buczacki et al., 2013).  
 
Figure 1.6 Intestinal stem cell hierarchy. Quiescent (Bmi1+ +4 cells) and active cycling 
(Lgr5+ CBC) intestinal stem cells produces absorptive progenitor, which give rise to 
enterocyte, and secretory precursor cell that located around the +4 position and generates 
cycling secretory progenitor cells, which produce goblet, Paneth and enteroendocrine 
cells. Both precursor and progenitor cell can repopulate Lgr5+ CBC cycling stem cell 
after loss of Lgr5+ CBC cell by injury. Adapted from (Visvader and Clevers, 2016). 
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Intestinal stem cells and crypts from the adult intestine grow into three-
dimensional intestinal organoids in culture with Matrigel matrix (Jung et al., 2011; Sato 
et al., 2009). These organoids consist of crypt and villus domains, and contain stem cell 
and all the differentiated cell types, which mimic the in vivo structure of the intestinal 
epithelium (Figure 1.7). Intestinal organoid growth requires epidermal growth factor and 
R-spondin1, which enhances Wnt signaling via Lgr receptors (Figure 1.3; (Carmon et al., 
2012; de Lau et al., 2011)).  
 
Figure 1.7 Intestinal organoid structure. Intestinal organoid forms new crypt-villus 
axis by stem cell renewal and differentiation. Adapted from (Roeselers et al., 2013) 
 However,	   intestinal	  progenitor	   cells	   from	   fetal	   and	  neonatal	   intestine	   grow	  into	   undifferentiated	   hollow	   spheroids	   in	   the	   same	   culture	   condition	   (Figure	   1.8;	  (Fordham	  et	  al.,	  2013;	  Mustata	  et	  al.,	  2013)).	  These	  spheroids	  are	  morphologically	  similar	   to	   APC	   null	   adult	   organoids,	   but	   express	   low	   level	   of	   Wnt	   target	   genes	  including	  Lgr5	  and	  Axin2.	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Figure 1.8 Intestinal organoids and spheroids. Intestinal spheroid consists of highly 
proliferative cells without terminally differentiated cells. There is no crypt-villus domain 
in intestinal spheroid. Adapted from (Fordham et al., 2013)  
 
  
Intestinal Organoids Intestinal Spheroids 
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1.4 Epigenetic regulations in the intestinal epithelium 
	  
 While the signaling pathways and transcriptional regulators involved in intestinal 
development and homeostasis have been investigated extensively, the role of epigenetic 
factors in these processes is largely unknown. Epigenetics is defined as heritable 
phenotypic traits, which affect gene function but are independent of alteration to the 
DNA sequence itself (Jaenisch and Bird, 2003). Epigenetic control is important for the 
establishment of cell-specific gene expression profiles and thus for self-renewal and 
differentiation of stem cells (Spivakov and Fisher, 2007). There are two main 
components of epigenetic modification - histone modifications and DNA methylation 
(Figure 1.9). 
 
Figure 1.9 Two main components of epigenetic modification. DNA methylation is a 
process by which a methyl group is added to cytosine, mostly on cytosine-guanine 
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dinucleotide. Histone modification is a covalent post-translation modification including 
methylation and acetylation in globular domain or tail. Adapted from (Qiu, 2006). 
 
 DNA is wrapped around the histone octamer, which contains two copies each of 
the histone proteins H2A, H2B, H3, and H4, and is packed into chromatin. The basic unit 
of chromatin is the nucleosome that consists of 147 base pair of DNA and a histone 
octamer (Luger et al., 1997). Post-translational modifications on histone proteins alter 
DNA accessibility and transcription during cell fate determination by themselves, or by 
recruiting effector proteins (Jenuwein and Allis, 2001; Tropberger and Schneider, 2013). 
Methylation (Me) and acetylation (Ac) on lysine (K) residue of the histone 3 (H3) tail 
have been the best characterized histone modifications to date. Although H3K4me3 and 
H3K27me3 mark active and inactive genes, respectively, they are co-localized as bivalent 
modifications at developmental genes poised for rapid activation following a 
differentiation signal (Bernstein et al., 2006; Ringrose and Paro, 2004). With regards to 
promoter-distal regulatory elements, H3K4me2 and H3K27Ac are enriched at active 
enhancers, which are also frequently occupied by the histone acetyltransferase p300. 
Poised enhancers have both H3K4me1 and H3K27me3, and are also often bound by the 
Polycomb Repressive Complex 2 (PRC2) (Figure 1.10; (Zhou et al., 2011)).  
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Figure 1.10 Histone modifications in gene regulation. H3K4me2 and H3K27Ac mark 
active enhancers with the histone acetyltransferase p300, lineage-specific transcription 
factors and RNA polymerase II, producing enhancer RNAs (eRNAs). Poised enhancers 
have H3K4me1 and H3K27me3 with the Polycomb Repressive Complex 2 (PRC2), and 
do not give rise to eRNAs. Repressed enhancers are enriched in H3K27me3 and PRC2, 
and are characterized by dense nucleosome packing. Adapted from (Nguyen et al., 2015). 
 
Genome-wide H3K4me2 profiles in Lgr5+ intestinal stem cells, secretory 
progenitors, and enterocytes are relatively similar (Kim et al., 2014). This finding 
suggests that enhancer chromatin is ‘open’ in any cell type of the intestinal epithelium, 
but their activities might be regulated by other epigenetic modifications or transcription 
factor bindings for proper differentiation.  
Another major epigenetic modification is methylation at the 5-carbon of the 
cytosine resulting in 5-methylcytosine (5mC). 5mC plays critical roles in many biological 
processes such as gene silencing, genomic imprinting, and genomic stability by 
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suppressing transposable and repetitive elements (Miranda and Jones, 2007). There are 
three DNA methyltransferases (Dnmt), termed ‘Dnmt1, -3a and -3b’ in mammals. 
Dnmt3a and -3b are classified as de novo methyltransferases and Dnmt1 is considered as 
maintenance methyltransferase to copy methylation pattern to newly synthesized 
daughter strands during replication, although this strict biochemically based classification 
has been challenged recently by in vivo gene ablation studies (Elliott et al., 2016). Mice 
with ablation of the Dnmt genes exhibit global hypomethylation, and embryonic lethality, 
suggesting an essential role for methylation during development (Figure 1.11; (Bestor, 
2000)). 
 
Figure 1.11 De novo and maintenance DNA methylation. Initial methylation patterns 
are established by the de novo DNA methyltransferases DNMT3A and DNMT3B during 
early development, When DNA replication and cell division occur, the maintenance 
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methyltransferase, DNMT1 maintains established methylation patterns in daughter cells. 
Adapted from (Wu and Zhang, 2010). 
 
Alterations of the DNA methylome during the process of differentiation of Lgr5+ 
intestinal stem into differentiated villus cells in adult mice have been reported recently 
(Kaaij et al., 2013; Sheaffer et al., 2014). Genes highly expressed in Lgr5+ intestinal stem 
cells, such as Olfm4 and ‘Hes family basic helix-loop-helix transcription factor 1’ (Hes1), 
gain methylation while their expression is repressed in differentiated cells. Intestinal 
enterocyte marker genes, such as alkaline phosphatase, intestinal (Alpi) and lactase (Lct), 
lose DNA methylation during the differentiation process, which correlates with increased 
binding of Cdx2 and its partner protein Hepatocyte Nuclear Factor 4α (Hnf4α), and 
activation of gene expression in differentiated cells (Figure 1.12; (Kaaij et al., 2013; 
Sheaffer et al., 2014)). Conditional deletion of Dnmt1 in the entire intestinal epithelium 
or in Lgr5+ stem cells of adult mice leads to crypt expansion or altered stem cell 
morphologies, respectively (Figure 1.12; (Sheaffer et al., 2014; Yu et al., 2015)).  
 
Figure 1.12 DNA methylation changes in the intestinal epithelium. Lgr5+ intestinal 
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stem cells (LGR5+ ISC), differentiated intestinal epithelial cells (DIFF IEC), and Dnmt1-
deleted intestinal epithelium (ΔDNMT1). Adapted from (Sheaffer et al., 2014) 
 
Loss of Tcf4 correlates with increased methylation levels at the differentially 
methylated regions, which are located near Tcf4 binding sites in intestinal crypt (Kaaij et 
al., 2013; Schuijers et al., 2014; van Es et al., 2012a). These findings suggest that the 
dynamics of DNA methylation plays an important role in enhancer activities, and is 
associated with Wnt target genes in intestinal epithelial differentiation.  
Loss of Dnmt1 in the developing intestine results in severe intestinal 
abnormalities and partial lethality before weaning (Figure 1.13; (Elliott et al., 2015; Yu et 
al., 2015)). These results demonstrate that DNA methylation plays an important role in 
intestinal maturation and homeostasis. 
 
Figure 1.13 DNA methylation is essential for the postnatal intestinal maturation. 
Intestinal epithelium specific deletion of Dnmt1 in the developing intestine. Loss of 
Dnmt1 shows villus atrophy and vacuolated cells in the intestinal epithelium of postnatal 
day 7 mice. Adapted from (Yu et al., 2015) 
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1.5 TET-mediated DNA hydroxymethylation in DNA demethylation pathway 
	  
DNA methylation is relatively stable epigenetic modification, but its levels are 
tightly regulated during development (Reik et al., 2001). In primordial germ cells and 
zygotes of mammals, for example, global 5mC decreases rapidly, suggesting a precise 
mechanism of DNA demethylation. Ten-eleven translocation (TET) enzymes are 
identified as dioxygenases that can convert 5mC to 5-hydroxymethylcytosine (5hmC) in 
various mammalian cells such as embryonic stem cells, brain and bone marrow 
(Kriaucionis and Heintz, 2009; Li and Liu, 2011; Tahiliani et al., 2009).  
5hmC and TET enzymes are involved in both passive and active DNA 
demethylation in mammals (Wu and Zhang, 2010). 5hmC can facilitate passive 
demethylation during replication due to poor recognition of the 5hmC-modified DNA 
segments by the maintenance DNA methyltransferase DNMT1 (Inoue and Zhang, 2011; 
Valinluck and Sowers, 2007). In terms of active demethylation, TET enzymes are able to 
further oxidize 5hmC to 5-formylcytosine (5fC) and 5-carboxycytosine (5caC), which are 
excised by thymidine DNA glycosylase (TDG), followed by replacement of abasic sites 
with unmethylated cytosines by the base excision repair pathway (Figure 1.14; (He et al., 
2011; Maiti and Drohat, 2011)). These findings suggest that 5hmC is the first step of 
DNA demethylation and may be involved in transcriptional activation by removing 
repressive 5mC (Ficz et al., 2011; Nestor et al., 2012).  
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Figure 1.14 5mC oxidation and demethylation process. 5mC is generated by DNMT, 
which can be oxidized by TET enzymes to generate 5hmC, 5fC and 5caC. All oxidative 
derivatives can be diluted out during replication, due to lack of recognition of DNMT1 
(Passive demethylation). 5fC and 5caC can be excised by TDG and repaired by the base 
excision repair mechanism to C (Active demethylation). Adapted from (Ficz, 2015) 
 
The mammalian Tet gene family has three members: Tet1, Tet2 and Tet3 (Ito et 
al., 2010). All of Tet proteins contain a C-terminal catalytic domain that exhibits Fe2+ and 
2-oxoglutarate-dependent dioxygenase activity and oxidize 5mC to 5hmC/5fC/5caC (Ito 
et al., 2011). This catalytic domain is used for a targeted DNA demethylation at 
endogenous loci by fusing to engineered transcription activator–like effector (TALE) 
repeat arrays. TALE-TET catalytic domain fusion protein can lead to demethylation at 
the targeted promoters in human cells and upregulation of endogenous human gene 
expressions (Maeder et al., 2013).  
Tet1 is highly expressed in ES cells and is required for normal ES cell 
differentiation (Dawlaty et al., 2011; Ito et al., 2010). Tet1-/- mice on a mixed background 
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are grossly normal, but have a smaller body size than litter mate controls during the 
postnatal period and exhibit defects in memory function (Dawlaty et al., 2011; Rudenko 
et al., 2013; Xin et al., 2015; Zhang et al., 2013). In contrast, a different allele of Tet1-/- 
mice on a pure C57BL/6 background showed partial embryonic lethality, smaller body 
size, and defects in fertility (Kang et al., 2015; Yamaguchi et al., 2012). Tet2-/- mice 
develop abnormally high numbers of myeloid cells and blood cancer in adulthood. Tet2 
loss in hematopoietic stem cells leads to increased stem cell self-renewal, DNA 
hypermetylation at active enhancers and leukemogenesis (Ko et al., 2011; Moran-Crusio 
et al., 2011; Quivoron et al., 2011; Rasmussen et al., 2015; Shide et al., 2012). Tet3-/- 
mice show embryonic and neonatal lethality (Gu et al., 2011). Tet3 followed by Tet2 are 
the most highly expressed Tet genes in the embryonic mouse brain, and their expression 
levels are increased during neuronal differentiation along with the increase of 5hmC 
levels. Loss of Tet3 and/or Tet2 causes a defect in neural progenitor cell maintenance and 
differentiation during brain development (Hahn et al., 2013; Li et al., 2015; Lister et al., 
2013). 
In chapter 2, I will present a novel role for TET1-mediated DNA 
hydroxymethylation in Wnt target gene expression in intestinal maturation and 
homeostasis.  
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1.6 An Independent Role of 5hmC in Gene Regulation 
	  
 The levels of 5hmC in various tissues is much greater than would be expected if it 
were just an intermediate product in the DNA demethylation pathways, and are also 
dynamically changed during differentiation and aging (Bachman et al., 2014; Szulwach et 
al., 2011b; Tahiliani et al., 2009). Thus, 5hmC may be a new semi-stable epigenetic 
mark, recruiting unique chromatin or transcriptional modifiers, and providing another 
level of gene expression regulation (Frauer et al., 2011; Mellén et al., 2012; Spruijt et al., 
2013; Yildirim et al., 2011). 
 Although the enrichment 5hmC in promoters and gene bodies is correlated with 
active gene expression (Figure 1.15; (Ficz et al., 2011; Song et al., 2010)), 5hmC is also 
found at bivalent promoters of poised developmental genes (Figure 1.15; (Pastor et al., 
2011; Wu et al., 2011)). This indicates 5hmC may have a role in pausing or silencing 
gene expression (Robertson et al., 2011; Szulwach et al., 2011a). Dual functions of 5hmC 
in gene regulation could be explained by its key role as a central node in epigenomic 
network in ES cells (Juan et al., 2016). 
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Figure 1.15 The dual role of 5hmC and TET in gene regulation. 5hmC and TET 
proteins may block DNMTs or Methyl-binding proteins to maintain unmethylated status 
in active gene promoter. However, 5hmC and TET enzymes are also found in regulatory 
regions of transcriptionally poised gene, interacting with the SIN3A co‐repressor 
complex and PRC. Adapted from (Branco et al., 2012). 
 
 In chapter 3, I will present a repressive role for 5hmC at putative distal enhancers, 
which is characterized by transcription factor bindings and absence of histone enhancer 
marks, and suggests that 5hmC is a new epigenetic mark for silenced enhancers. 
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2.1 Summary 
	  
Methylated cytosines are associated with gene silencing. The Ten-eleven 
Translocation (TET) hydroxylases, which oxidize methylated cytosines to 5-
hydroxymethylcytosine (5hmC), are essential for cytosine demethylation. Gene silencing 
and activation are important processes in intestinal stem cell (ISC) differentiation and 
maintenance, but the potential role of TET hydroxylases in these processes has not yet 
been examined. Here, we generate genome-wide maps of the 5hmC mark in ISCs and 
their differentiated progeny. Genes with high levels of hydroxymethylation in ISCs are 
strongly associated with Wnt signaling and developmental processes. We thus 
investigated Tet1-deficient mice and found that they are growth-retarded, exhibit partial 
postnatal lethality, and have significantly reduced numbers of proliferative cells in the 
postnatal intestine. In the Tet1-deficient crypt, decreased expression of Wnt target genes 
such as Axin2 and Lgr5 correlates with lower 5hmC levels at the promoter of Wnt target 
genes. These data demonstrate that Tet1-mediated DNA hydroxymethylation plays a 
critical role in the epigenetic regulation of the Wnt pathway in intestinal stem and 
progenitor cells, and consequently in the self-renewal of the intestinal epithelium. 
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2.2 Background 
 
DNA methylation is a widespread epigenetic modification that regulates gene 
expression in development and cellular differentiation (Reik et al., 2001; Sheaffer et al., 
2014; Smith and Meissner, 2013). DNA methylation is dynamic, yet tightly regulated to 
prevent aberrant patterns of 5-methylcytosine (5mC), which are common in cancer 
(Baylin et al., 2001; Esteller, 2007). 5mC is established and maintained by DNA 
methyltransferase (DNMT) enzymes (Li et al., 1992; Okano et al., 1999). Recently, 
oxidation of 5mC to 5-hydroxymethylcytosine (5hmC) by the Ten-eleven translocation 
(TET) gene family was proposed as a novel mechanism for removal of 5mC (Kriaucionis 
and Heintz, 2009; Tahiliani et al., 2009). This can occur by at least two non-mutually 
exclusive mechanisms. First, 5hmC can be further oxidized to 5-formlyctosine (5fC) and 
then 5-carboxylcytosine (5caC), again by the Tet enzymes, though at much lower 
efficacy than oxidation from 5mC to 5hmC (Ito et al., 2011). Both 5fC and 5caC can be 
glycosylated by thymine DNA glycosylase and replaced by unmodified cytosine via base 
excision repair (Maiti and Drohat, 2011; Weber et al., 2016). Second, because 
hemimethylated 5hmC nucleotides are not recognized by the maintenance DNA 
methyltransferases following DNA replication during S-phase, hydroxymethylation of 
specific sites will lead to their targeted, passive demethylation in replicating cells. Thus, 
hydroxymethylation via the Tet enzymes offers an elegant pathway for even lineage-
committed cells to change their DNA methylation status.  
Global methylome analyses in recent years have shown that the DNA methylation 
status is dynamic with aging even within the same cell type (Avrahami et al., 2015). 
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Likewise, we and others have demonstrated previously that DNA methylation at specific 
loci changes during differentiation of intestinal stem cells (ISCs) to enterocytes in adult 
mice (Kaaij et al., 2013; Sheaffer et al., 2014) and during ISC maturation in the postnatal 
mice (Yu et al., 2015); however, how these elements are targeted for demethylation is 
currently unknown.  
The epithelium of the small intestine is the most rapidly self-renewing tissue in 
mammals, and even in humans the epithelium is replaced every three to five days. Active 
Wnt signaling in the intestinal crypt is a major driving force for intestinal stem cell 
renewal and proliferation of transit-amplifying cells. Tight regulation of Wnt signaling is 
critical for the intestinal epithelial homeostasis (Gregorieff and Clevers, 2005). Rapidly 
cycling Lgr5+ stem cells at the bottom of the intestinal crypt give rise to transit-
amplifying cells that divide up to six times further (Rao and Wang, 2010) before 
differentiating into post-mitotic, functional cells as they exit the crypt zone and migrate 
up the crypt-villus axis. This process is accompanied by dramatic changes in the 
transcriptional program, which are mediated, at least in part, by epigenetic changes such 
as the aforementioned realignment of DNA methylation status (Kaaij et al., 2013; 
Sheaffer et al., 2014). In fact, in the absence of Dnmt1 alone or both Dnmt1 and Dnmt3b, 
the intestinal epithelium is not viable in the postnatal period (Yu et al., 2015) or in adult 
(Elliott et al., 2016), respectively. Here, we investigate to what extent targeted oxidation 
of 5mC to 5hmC contributes to intestinal epithelial health.  
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2.3 Methods 
 
Mice. All procedures involving mice were conducted under a protocol approved by the 
Institutional Animal Care and Use Committee (IACUC) of the University of 
Pennsylvania. Eight to twelve week-old C57BL/6J mice were used for all experiments 
unless noted otherwise. For sorting of Lgr5+ stem cell, we employed Lgr5-EGFP-Ires-
CreERT2 mice (Barker et al., 2007). Tet1-/- mice (Dawlaty et al., 2011) were backcrossed 
to C57BL/6J mice for five generations. Eight week-old Tet1+/- mice were then 
intercrossed to generate Tet1-/- mice. Pups were monitored for litter size and body weight 
gain. Survival rate calculation and statistical analyses were performed using Prism 
Graphpad software. Tet1+/- mice were crossed to Lgr5-EGFP-Ires-CreERT2 mice and 
Tet1+/-;Lgr5-EGFP-Ires-CreERT2 mice were intercrossed to generated Tet1-/-;Lgr5-
EGFP-Ires-CreERT2 mice.  
 
Dot Blot. For the analysis of hydroxymethylation levels, DNA samples were denatured at 
95  °C for 10 min and spotted onto Hybond-N+ nitrocellulose membranes (GE 
Healthcare). The membrane was blocked with CAS-Block (Thermo Fisher Scientific), 
followed by overnight incubation with an anti-5hmC antibody (Active Motif) at 4°C. 
Membranes were incubated with horseradish peroxidase (HRP)-conjugated goat anti-
mouse antibodies (GE Healthcare) for 30 min at room temperature and developed using 
the ECL+ prime blotting detection system (GE Healthcare). 
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Immunohistochemistry. Dissected tissues were washed in cold PBS and fixed overnight 
in 4% paraformaldehyde at 4°C before paraffin embedding. Antigen retrieval was 
performed using Retriever in buffer A (Electron Microscopy Sciences), and tissue 
sections were incubated overnight at 4°C with anti-5hmC (Active Motif), anti-Ki67 (BD 
Pharmingen), anti-Axin2 (Abcam), anti-Sox9 (Millipore), anti-CyclinD1 (Biocare 
Medical) and anti-GFP antibodies (Aves Labs). After incubation with secondary 
antibodies (Vector Lab) for 2hrs at room temperature, samples were mounted in 
fluorescent mounting medium (Dako) or developed using the Vectastain Elite ABC kit 
(Vector Lab). Images were acquired using a Nikon Eclipse 80i fluorescence microscope 
and a Leica SP8 confocal microscope.   
 
Lgr5+ cell, crypt, and villus isolation. Small intestines were dissected and opened 
longitudinally. The tissues were washed in cold PBS and scraped gently on the luminal 
side with a glass slide to obtain villus cells. The remaining tissue was incubated with 
rotation in 5mM EDTA/HBSS for 30 min at 4°C. After EDTA incubation, the tissue was 
vigorously shaken for 15 seconds. The first fraction was villus-rich and thus discarded. 
After further shaking, the supernatant enriched for intestinal crypts was passed through a 
70 µm cell strainer to remove residual villus material and was centrifuged at 600 rpm for 
2 min to collect crypts. For Lgr5+ cell sorting, isolated crypts were dissociated with 
TrypLe express (Thermo Fisher Scientific) for 20 min at 37°C and shaken every 5 min to 
prevent cell clumping. Dissociated cells were passed through a 40 µm cell strainer and 
washed with HBSS. GFP+ cells were separated on a FACS Diva (BD Bioscience).  
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DNA hydroxymethylation analysis. Genomic DNA was isolated from sorted Lgr5+ 
cells, crypt and villus cells using the AllPrep kit (Qiagen) and sonicated to an average 
size of 150-300 bp (Covaris). DNA fragments were denatured (10  min at 95  °C) and 
immunoprecipitated using 2µl of anti-5hmC antibody (Active Motif) and 10µl Protein G 
beads (Thermo Fisher Scientific) in IP buffer (10 mM sodium phosphate, pH 7.0; 140 
mM NaCl; 0.05% Triton X-100). For hMeDIP-qPCR, hydroxymethylated DNA and 
input DNA were quantified on an Mx3005P qPCR System (Applied Biosystems) using 
the Brilliant II SYBR Green QPCR master mix (Agilent). For hMeDIP-seq, DNA 
fragments were ligated with Illumina adaptors using the NEBNext® DNA Library Prep 
Master Mix Set (NEB). Following adaptor ligation, DNA fragments were denatured and 
immunoprecipitated using an anti-5hmC antibody (Active Motif). Hydroxymethylated 
DNA was amplified with adapter-specific primers (12 cycles). Amplified fragments 
ranging from 150 to 200 bp were size-selected followed by sequencing on a HiSeq2000 
(Illumina).  
 
Mapping of sequencing data and bioinformatics. Reads were aligned to the mouse 
reference genome (NCBI build 37, mm9) using Bowtie (Langmead et al., 2008). Only 
unique reads were used for peak calling and annotation by HOMER (Heinz et al., 2010). 
BedGraph files were generated and viewed on the UCSC Genome Browser. 
Differentially hydroxymethylated Regions (DhMRs) were determined by comparing 
5hmC peak levels in one sample to the other in each direction (fold change cutoff = 5, P 
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value cutoff = 1.00 x 10-4). Gene ontology analysis was performed with DAVID (Huang 
et al., 2009). 
 
RNA isolation, qPCR, and mRNA-seq analysis. Total RNA and complementary DNA 
(cDNA) were prepared using AllPrep kit (Qiagen,) and Superscript First-Strand synthesis 
system (Thermo Fisher Scientific). RT-qPCR reactions were performed on an Mx3005P 
qPCR System (Applied Biosystems) using Brilliant II SYBR Green QPCR master mix 
(Agilent). Relative expression levels were determined using comparative Ct values after 
normalizing to Tbp. RNA-seq method was previously detailed (Sheaffer et al., 2014).  
 
Intestine organoid culture. Isolated intestinal crypts were resuspended in Matrigel 
(Corning) and covered with standard EGF/Noggin/R-spondin medium (Sato et al., 2009). 
Culture medium was changed every other day.  
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Table 2.1 RT-qPCR primers 
	  
Gene Strand Sequence 
Tet1 
F GAGCCTGTTCCTCGATGTGG  
R CAAACCCACCTGAGGCTGTT  
Tet2 
F AACCTGGCTACTGTCATTGCTCCA  
R ATGTTCTGCTGGTCTCTGTGGGAA  
Tet3 
F CCGGATTGAGAAGGTCATCTAC  
R AAGATAACAATCACGGCGTTCT  
Lgr5 
F TAAAGACGACGGCAACAGTG  
R GCCTTCAGGTCTTCCTCAAA  
Creb3l3 
F GAACAGGAACCAGAGCCCTTT  
R CTCTGCATCTTCCTGGTGGTC  
Vimentin 
F CGGAAAGTGGAATCCTTGCA  
R CACATCGATCTGGACATGCTGT  
Hemoglobin β 
F TGATGCTGAGAAGGCTGCTGTCTCTG  
R GTGCCCTTGAGGCTGTCCAAGTGA  
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Table 2.2 hMeDIP-qPCR primers 
	  
Name Genomic location Strand Sequence 
Lgr5 
promoter 
	   	   	  
chr10:115,026,111 
-115,026,229 
F AGGCCTGTTTTCAGTAAGTTTGTG 
R AAAGACCATGACTGCGCTCT 
Axin2 
promoter 
	   	   	  
chr11:108,780,916-­‐
108,781,024	  
 
F ATTCGAAGGTGACAGTGGGG 
R CACACTCTCCCAAAGGGCTG 
Sox9 
promter 
 
chr11:112,641,826-
112,641,940 
 
 
F CTCGTAAACAGGCTACAGGGT 
R TTGGGGAAAGGAACTCGTGA 
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2.4 Results 
 
5hmC level is high in intestinal villus epithelial cells 
To determine global 5hmC levels in ISCs, we performed 5hmC dot blot analysis 
of genomic DNA from isolated epithelial cells as well as brain and embryonic stem cells 
(ESCs) for comparison. We found that 5hmC levels in the gut are almost as high as those 
present in the brain and ESCs (Figure 2.1A). Hydroxymethylation of cytosines has been 
suggested to play an important role in neurons due to the abundance of this mark in the 
brain (Hahn et al., 2013; Rudenko et al., 2013). Therefore, we hypothesized that this 
epigenetic mark might also play an essential role in intestinal epithelial cells. We 
examined the distribution of global 5hmC compared to 5mC in the intestinal epithelium 
by immunofluorescence detection of each mark with specific antibodies. 5mC was 
present in all epithelial cells, with highest levels in the crypt where stem and transit-
amplifying cells reside (Figure 2.1B).  We identified proliferating stem and transit-
amplifying cells by co-staining with Ki67, a marker of proliferation. Interestingly, we 
found that the strongest 5hmC signal was detected in the nuclei of differentiated villus 
cells, while the signal decreased in the crypt region (Figure 2.1C). This finding is 
consistent with previous reports that 5hmC is depleted in proliferating cancer cells 
compared to post-mitotic cells (Jin et al., 2011; Lian et al., 2012).  
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Figure 2.1 Differential enrichment of DNA methylation and hydroxymethylation in 
the intestinal epithelium. (A) Dot blot shows global 5hmC levels in the mouse adult 
intestinal epithelium compared to brain and embryonic stem cells (ESCs). (B-C) 
Immunofluorescence staining of mouse jejunum with 5mC (B), 5hmC (C) and Ki67 
antibodies as indicated. Scale bars: 50µm.  
 
Dynamic changes of 5hmC distribution during intestinal epithelial differentiation 
Next, we examined dynamic genomic 5hmC abundance during ISC 
differentiation. First, we isolated Lgr5-expressing ISCs  (Lgr5+) from Lgr5-EGFP-IRES-
CreERT2 mice (Barker et al., 2007) by FACS sorting and differentiated villus epithelial 
cells by careful scraping of the luminal side of the gut tube (Figure 2.2; see detailed 
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description in Experimental Procedures). Genomic DNA was then isolated from both cell 
populations. To investigate genome-wide changes of the 5hmC mark between Lgr5+ and 
differentiated cells, we performed hydroxymethylated DNA immunoprecipitation 
followed by next-generation sequencing (hMeDIP-seq; see Experimental Procedures).  
 
Figure 2.2 Isolation of Lgr5+ intestinal stem and villus differentiated cells. (A) FACS 
plot to isolate Lgr5-EGFP+ cells and RT-qPCR validation for Lgr5 expression in GFP+ 
cells. (B) H&E staining image of scraped differentiated villus cells and RT-qPCR 
validation for cell-specific marker genes (Creb3l3: Enterocyte, Vimentin: Mesenchymal 
cells, Hemoglobin:  red blood cells).  
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Figure 2.3 Differential 5hmC distributions in intestinal stem and differentiated cells. 
(A–C) Screenshots of bisulfite sequencing (with measures 5mC and 5hmC) and hMeDIP-
sequencing (5hmC) at marker genes in Lgr5+ intestinal stem cells (A), Wnt target genes 
(B) and differentiated villus cells (C). Data are presented as % methylation for the 
bisulfite-sequencing data, and as reads per million mapped reads (RPM) for the 5hmC 
data. 
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Remarkably, we discovered striking differences in 5hmC levels marker genes for 
both ISCs and mature enterocytes (Figure 2.3). For example, high levels of 5hmC were 
present near promoters and throughout the gene bodies of ISC-marker genes such as 
Lgr5, Olfm4 and Msi1, and Wnt target genes such as Axin2, c-Myc and Sox9 in Lgr5+ 
cells but were decreased dramatically after differentiation into villus epithelial cells 
(Figure 2.3A-B, Figure 2.4A-B). Conversely, genes expressed at high levels only in 
differentiated cells, such as Alpi, Sis and Fabp1, were hydroxymethylated only in 
differentiated cells (Figure 2.3C, Figure 2.4C). 
 
Figure 2.4. Marker gene expression level in Lgr5+ stem and differentiated cells. (A) 
RNA-seq results for intestinal stem cell marker genes (B) RNA seq results for Wnt target 
genes (C) RNA-seq results for differentiated villus cell marker genes 
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Having established that the 5hmC mark is dynamic for the nine genes described 
above, we performed a genome-wide analysis of hydroxymethylation. We identified a 
total of 33,183 5hmC-enriched regions (peaks) in Lgr5+ cells and 100,707 peaks in 
differentiated cells using HOMER (Heinz et al., 2010) (Figure 2.5A), and about eight-
fold increase of 5hmC signal in differentiated cells relative to the 5hmC signal in Lgr5+ 
cells (Figure 2.5B). When comparing 5hmC peaks between the two cell populations, we 
identified 10,450 differentially hydroxymethylated regions (DhMRs) (≥5 fold, p < 
0.0001), and divided them into two groups – higher 5hmC in Lgr5+ DhMRs (n=2,537) 
and higher 5hmC in differentiated cells (n=7,903) (Figure 2.6A). The two groups of 
DhMRs displayed distinct genomic distribution patterns. While Lgr5+ DhMRs were 
enriched in intergenic regions, those present in differentiated cells were more likely to be 
located in gene bodies. We identified the closest gene for each DhMR and performed 
gene ontology analysis for the differentially hydroxymethylated gene sets (Figure 2.6B). 
The genes associated with higher 5hmC levels in Lgr5+ cells were involved in 
‘developmental process’ and ‘cell differentiation’, primary functions of stem cells. 
Conversely, the genes associated with higher 5hmC levels in differentiated cells were 
enriched for genes that control metabolic processes and nutrient transport, major 
functions of enterocytes. Thus, overall, high levels of hydroxymethylation correlated 
positively with the gene sets expressed in either Lgr5+ stem cells or post-mitotic, 
differentiated villus epithelial cells.  
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Figure 2.5 Overall 5hmC levels in Lgr5+ stem cells and differentiated cells. (A) Total 
number of 5hmC enriched regions (peaks) number counting and genomic distribution in 
Lgr5+ stem and differentiated cells (≥ 4-fold enrichment over local tag count, p-value < 
0.001). (B) The relative 5hmC signal of hMedIP-seq in Lgr5+ stem and differentiated 
cells. The ratio of hMeDIP/Input reads numbers in DIFF was set to 100%.  
 
 
Figure 2.6 Dynamics of 5hmC and gene expression changes during intestinal stem 
cell differentiation. (A) Genomic distribution of differentially hydroxymethylated 
regions (DhMRs). Upper pie chart: regions with 5hmC levels that are higher in Lgr5+ 
stem cells than in differentiated epithelial cells (DIFF) (at least 5 fold, p-value < 0.0001). 
Lower pie chart: regions with 5hmC levels that are higher in differentiated epithelial cells 
(DIFF) than in Lgr5+ stem cells (at least 5 fold, p-value < 0.0001). Circle size represents 
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the total number of DhMRs in each group.  (B) Gene ontology search results for genes 
closest to DhMRs. (C) Differential gene expression of differentially hydroxymethylated 
genes (≥1.5 fold change) during intestinal epithelial differentiation. RNA-seq data for 
both cell populations are represented as reads per kilobase per million mapped read 
(RPKM).   
 
Next, we examined the correlation between differential hydroxymethylation and 
differential gene expression, determined by RNA-seq (Sheaffer et al., 2014). Genes 
enriched for the 5hmC mark in Lgr5+ stem cells (n=1,181), including ISC-marker genes 
such as Olfm4, Lgr5 and Msi1, showed higher gene expression level in Lgr5+ stem cells 
than in differentiated villus epithelial cells (Figure 2.6C, left). Conversely, genes enriched 
for the 5hmC mark in differentiated cells (n=1,559) including villus differentiated cell 
marker genes such as Alpi, Sis and Fabp1, exhibited increased expression in 
differentiated cells (Figure 2.6C, right). Overall, gene expression changes correlated 
strongly with 5hmC level variation during ISC differentiation. However, we also noted 
some exceptions where gene expression levels were anti-correlated with 5hmC status. 
5hmC has been reported to have a role in transcriptional repression in specific cases 
including poised enhancers and promoters (Choi et al., 2014; Pastor et al., 2011; Wu et 
al., 2011).  
 
Tet1 is required for postnatal intestinal development 
Having determined that hydroxymethylation is highly dynamic during 
differentiation of ISCs into functional villus epithelial cells, we investigated which of the 
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Tet enzymes is most likely controlling this process. We measured Tet1, 2 and 3 mRNA 
expression levels in Lgr5+ stem and in differentiated villus cells by RT-qPCR (Figure 
2.7). Tet1 was expressed at much higher levels in Lgr5+ stem cells than in differentiated 
cells, while Tet2 and 3 showed the opposite pattern. These data suggested that Tet1 might 
have an essential role in Lgr5+ ISC function.  
 
Figure 2.7 Differential expression of Tet1-3 in Lgr5+ stem and differentiated cells. 
Relative mRNA expression level of Tet1 (A), Tet2 (B) and Tet3 (C) in Lgr5+ stem and 
differentiated cells. Relative to Tbp. 
 
Next, we phenotyped Tet1 null mutant mice (Dawlaty et al., 2011) during 
postnatal development, when gastro-intestinal function first becomes relevant (Table 2.3). 
Strikingly, we found that Tet1-deficient mice were growth-retarded during the early 
postnatal period (Figure 2.8A), exhibited a much smaller body size (Figure 2.8B), and 
showed significant postnatal lethality (Figure 2.8C). In fact, viability of Tet1-/- mice was 
already significantly impaired by postnatal day 3 (Figure 2.8D).  
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Table 2.3 Previous and current studies of Tet1 null mice 
Tet1 ablation studies Allele Background Phenotype 
(Dawlaty et al., 2011) 
(Rudenko et al., 2013) exon 4 deletion 
129Sv, C57BL/6 
Mixed 
viable, fertile, 
impaired memory 
extinction 
(Yamaguchi et al., 
2012) 
gene-trap cassette 
into the 1st intron 
6X backcrossed 
to C57BL/6 
partial embryonic lethal, 
reduces female germ-
cell and fertility 
(Zhang et al., 2013) 
(Xin et al., 2015) 
exon 11-13 
deletion 
129Sv, C57BL/6 
Mixed 
viable, fertile, impaired 
learning and short-term 
memory 
(Kang et al., 2015) exon 9-10 deletion C57BL/6 
partial embryonic lethal, 
hydrocephalus, 
degenerated ovaries 
Current work exon 4 deletion 5x backcrossed to C57BL/6 
partial postnatal lethal, 
intestinal defects 
	  
 
Figure 2.8 Postnatal growth retardation and lethality of Tet1 null mice. (A) Tet1 null 
mice are growth-retarded. Weight curve during the postnatal period, ** P-value < 0.01 by 
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t-test. (B) Representative Tet1+/+ and Tet1-/- mice on postnatal day 11 (P11).	  (C) Survival 
curve during postnatal period, *** P-value < 0.001 by a Log-rank (Mantel-Cox) test. (D) 
Reduced perinatal viability of Tet1 homozygous mutants. Mice were quantified on 
postnatal day 3. *** P-value < 0.0005 (chi-square test) 
 
The intestines of Tet1-deficient mice were thinner and shorter than those of wild-
type littermates (Figure 2.9A). On histological examination, we found both villus length 
and proliferating cell number per crypt to be significantly reduced in Tet1-null mice 
compared to wild-type littermates (Figure 2.9B-D). Thus, Tet1 plays an important role in 
the maturation of the postnatal intestine.  
 
Figure 2.9 Developmental defects during postnatal intestinal maturation. (A) 
Representative image of intestinal tracts of Tet1+/+ and Tet1-/- mice at one week of age. 
(B) Histological analysis of Tet1+/+ and Tet1-/- jejunum of one week-old mice.  
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Proliferating cells are marked by immunohistochemistry for Ki67 (dark brown signal). 
Scale bars: 50µm (C) Villus length comparison between Tet1+/+ and Tet1-/- one week-old 
jejunum (*** P-value < 0. 001). (D) Ki67+ cell number per crypt is reduced in one week-
old Tet1-/- jejunum, compared littermate controls. (*** P-value < 0. 001). 
 
Wnt target genes and Lgr5 expression in the postnatal intestine is dependent on Tet1 
function  
Since Wnt signaling is essential for intestinal maturation and proliferation, we 
reasoned Wnt target gene expression might be affected in the Tet1-deleted intestine. To 
examine Wnt target gene expression levels, we performed immunostaining for Wnt 
molecules in one week-old Tet1-/- jejunum compared to wild-type littermate. Expression 
of Wnt target genes such as Axin2, Sox9 and Cyclin D1 were clearly reduced in mutant 
intestine (Figure 3.10).  
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Figure 3.10 Decreased level of Wnt target gene expression in the postnatal Tet1 null 
mice intestine. Immunofluorescence stains of Wnt target proteins such as (A) Axin2 (B) 
Sox9 and (C) Cyclin D1 in postnatal day 7 Tet1+/+ and Tet1 -/- mice. Scale bars: 100µm  
 
To evaluate the consequences of Tet1-deficiency on ISCs, we crossed Tet1 mutant 
mice with Lgr5-EGFP-IRES-CreERT2 mice, which allows for the easy detection of 
Lgr5+ stem cells via expression of EGFP. We found a dramatic reduction in the 
frequency of Lgr5-EGFP positive cells in the crypt of the postnatal and adult Tet1-null 
jejunum by immunofluorescence staining and FACS (Figure 3.11). Thus, Tet1 is required 
for maintaining Wnt target gene expression and Lgr5 expression during intestine 
maturation. 
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Figure 3.11 Reduction of Lgr5 expression in Tet1 null mice intestine. (A) Decreased 
Lgr5-EGFP expression levels in two-week old and two-month old Tet1 null jejunum as 
detected by immunofluorescence stains of GFP (green). Scale bars: 20µm (B) FACS 
analysis demonstrates loss of Lgr5-EGFP+ cells in two-month old Tet1-/- mice.  (C) 
Quantification of Lgr5-EGFP positive cell number in two-month old Tet1+/+ and Tet1 -/- 
mice. *** P-value < 0.001 (n=4) 
 
Decreased 5hmC levels at Wnt target loci leads to spheroid formation  
Next, we investigated stem cell function using intestinal crypt culture. We found 
significantly decreased mature organoid-forming efficiency and reduced level of Wnt 
target/ISC marker gene expression in cultures derived from Tet1-deficient intestine 
(Figure 3.12). This finding suggests that the state of postnatal crypt from Tet1-/- mice is 
more close to fetal crypt than adult crypt (Fordham et al., 2013; Mustata et al., 2013). 
 
	  61	  
 
Figure 3.12 Mature organoid-forming potential is reduced in the absence of Tet1. 
Images of intestinal organoid formation from two-week old Tet1+/+ and Tet1-/- jejunal 
crypts. Scale bars: 10µm. (B) Quantification of intestinal organoid volume after nine days 
of culture. ** P-value < 0.01 (n=3).  (C) Ratio of mature budding organoids over total 
organoids. * P-value < 0.05 (n=3). (D) Differential gene expression in Tet1 -/- premature 
spheroid compared to Tet1+/+ mature organoid.  
 
To ascertain if the decrease in Wnt target genes and Lgr5 expression in Tet1-/- 
mice was caused by altered hydroxymethylation levels, we analyzed 5hmC levels at their 
loci in control and mutant mice. We found significantly decreased 5hmC levels at their 
promoter region in Tet1 null mice by 5hmC immunoprecipitation followed by qPCR 
analysis (Figure 3.13), which correlated with decreased Wnt target genes and Lgr5 
expression levels (Figure 3.10 and 3.11). This finding suggests that Tet1 is critical for 
hydroxymethylation followed by demethylation to allow for full activation of Wnt target 
and stem cell genes. 
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Figure 3.13 Differential 5hmC level at the promoter of Wnt target genes. hMeDIP-
qPCR results at the promoter of Lgr5, Axin2, Sox9 in two-week old Tet1+/+ and Tet1-/- 
crypts.  * P-value < 0.05 (n=3).  
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2.5 Discussion 
 
In this study, we document dynamic changes of 5hmC at key gene loci during ISC 
differentiation and report that Tet1-mediated hydroxymethylation is essential for ISC 
function. 5hmC was enriched at promoters and gene bodies of highly expressed genes in 
each cell type and may reverse the repressive effect of 5mC for gene activation. Tet1 was 
expressed in ISCs, not in differentiated villus cells.  
Tet1-/- mice on a mixed genetic background (129Sv, C57BL/6) were previously 
reported to be viable and fertile with no morphological and growth abnormalities 
(Dawlaty et al., 2011; Zhang et al., 2013), but adult Tet1-/- mice exhibited defective self-
renewal of neural progenitor cells (Rudenko et al., 2013; Xin et al., 2015; Zhang et al., 
2013) and hematopoietic stem cells (Cimmino et al., 2015). However, after backcrossing 
onto the C57BL/6 background, we observed decreased postnatal viability and striking 
intestinal defects in these mice. Recently, Kang and colleagues also reported that Tet1-
deficient C57BL/6 mice exhibit partial embryonic lethality and growth retardation (Kang 
et al., 2015); however, intestinal health was not examined in the prior study. We found 
that Tet1-/- mice showed shortened intestinal length, reduced proliferating cell number 
and villus height in the postnatal intestine, which is similar to the phenotype seen in mice 
with conditional deletion of Dnmt1 in the developing intestine using Dnmt1f/f; VillinCre 
mice (Elliott et al., 2015; Yu et al., 2015).  
Lgr5 is known as one of Wnt target gene and an adult stem cell marker gene in 
the intestine (Barker et al., 2007), but a limited number of Lgr5+ cells are also presented 
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in the intervillus zone of the developing intestine at E 16.5 (Kinzel et al., 2014). During 
intestinal maturation in the postnatal period, these Lgr5+ cells are rapidly cycling at the 
bottom of the crypt and clearly exhibit stem-cell properties at this stage (Kim et al., 
2012). Here, we show that 5hmC enrichment at Wnt target loci in Lgr5+ stem cells is 
required for full activation of gene expression, and homozygous deletion of Tet1 causes 
significantly decreased 5hmC levels at these loci, resulting in a dramatically reduced Wnt 
target genes and Lgr5 expression during postnatal intestinal maturation. Importantly, loss 
of Tet1 also impairs mature organoid-forming capacity and thus stem-cell function of 
small intestinal crypts. In culture, intestinal spheroids were generated from fetal intestine, 
and exhibited low level of Wnt target gene expression (Mustata et al., 2013), which is 
similar to what we generated from Tet1-deleted postnatal intestine. Our data demonstrate 
that Tet1-mediated conversion from 5mC to 5hmC is an important epigenetic mechanism 
regulating expression of Wnt target genes including Lgr5 during postnatal intestinal 
maturation. 
The definitive role of Tet1-mediated DNA hydroxymethylation in the intestine 
warrants further investigation using conditional gene ablation models. Nevertheless, our 
results demonstrate that 5hmC is an essential epigenetic mark required for ISC function. 
DNA hydroxymethylation could be a switch to activate key genes in stem cells and 
represents a novel mechanism of gene regulation during stem cell differentiation.  
 
  
	  65	  
2.6 Reference 
	  
Avrahami, D., Li, C., Zhang, J., Schug, J., Avrahami, R., Rao, S., Stadler, M.B., Burger, 
L., Schübeler, D., Glaser, B., et al. (2015). Aging-Dependent Demethylation of 
Regulatory Elements Correlates with Chromatin State and Improved β Cell Function. 
Cell Metab 22, 619-632. 
Barker, N., van Es, J.H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen, M., 
Haegebarth, A., Korving, J., Begthel, H., Peters, P.J., et al. (2007). Identification of stem 
cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003-1007. 
Baylin, S.B., Esteller, M., Rountree, M.R., Bachman, K.E., Schuebel, K., and Herman, 
J.G. (2001). Aberrant patterns of DNA methylation, chromatin formation and gene 
expression in cancer. Hum Mol Genet 10, 687-692. 
Choi, I., Kim, R., Lim, H.-W.W., Kaestner, K.H., and Won, K.-J.J. (2014). 5-
hydroxymethylcytosine represses the activity of enhancers in embryonic stem cells: a 
new epigenetic signature for gene regulation. BMC genomics 15, 670. 
Cimmino, L., Dawlaty, M.M., Ndiaye-Lobry, D., Yap, Y., Bakogianni, S., Yu, Y., 
Bhattacharyya, S., Shaknovich, R., Geng, H., Lobry, C., et al. (2015). TET1 is a tumor 
suppressor of hematopoietic malignancy. Nat Immunol 16, 653-662. 
Dawlaty, M.M., Ganz, K., Powell, B.E., Hu, Y.-C.C., Markoulaki, S., Cheng, A.W., Gao, 
Q., Kim, J., Choi, S.-W.W., Page, D.C., et al. (2011). Tet1 is dispensable for maintaining 
pluripotency and its loss is compatible with embryonic and postnatal development. Cell 
stem cell 9, 166-175. 
Elliott, E.N., Sheaffer, K.L., and Kaestner, K.H. (2016). The 'de novo' DNA 
methyltransferase Dnmt3b compensates the Dnmt1-deficient intestinal epithelium. eLife 
5. 
Elliott, E.N., Sheaffer, K.L., Schug, J., Stappenbeck, T.S., and Kaestner, K.H. (2015). 
Dnmt1 is essential to maintain progenitors in the perinatal intestinal epithelium. 
Development 142, 2163-2172. 
Esteller, M. (2007). Cancer epigenomics: DNA methylomes and histone-modification 
maps. Nat Rev Genet 8, 286-298. 
	  66	  
Fordham, R.P., Yui, S., Hannan, N., Soendergaard, C., Madgwick, A., Schweiger, P.J., 
Nielsen, O.H., Vallier, L., Pedersen, R.A., Nakamura, T., et al. (2013). Transplantation of 
Expanded Fetal Intestinal Progenitors Contributes to Colon Regeneration after Injury. 
Cell Stem Cell. 
Gregorieff, A., and Clevers, H. (2005). Wnt signaling in the intestinal epithelium: from 
endoderm to cancer. Genes Dev 19, 877-890. 
Hahn, M.A., Qiu, R., Wu, X., Li, A.X., Zhang, H., Wang, J., Jui, J., Jin, S.-G.G., Jiang, 
Y., Pfeifer, G.P., et al. (2013). Dynamics of 5-hydroxymethylcytosine and chromatin 
marks in Mammalian neurogenesis. Cell Rep 3, 291-300. 
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y.C., Laslo, P., Cheng, J.X., Murre, 
C., Singh, H., and Glass, C.K. (2010). Simple combinations of lineage-determining 
transcription factors prime cis-regulatory elements required for macrophage and B cell 
identities. Mol Cell 38, 576-589. 
Huang, D.W.a.W., Sherman, B.T., and Lempicki, R.A. (2009). Systematic and integrative 
analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44-57. 
Ito, S., Shen, L., Dai, Q., Wu, S.C., Collins, L.B., Swenberg, J.A., He, C., and Zhang, Y. 
(2011). Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-
carboxylcytosine. Science 333, 1300-1303. 
Jin, S.-G.G., Jiang, Y., Qiu, R., Rauch, T.A., Wang, Y., Schackert, G., Krex, D., Lu, Q., 
and Pfeifer, G.P. (2011). 5-Hydroxymethylcytosine is strongly depleted in human cancers 
but its levels do not correlate with IDH1 mutations. Cancer Res 71, 7360-7365. 
Kaaij, L.T., van de Wetering, M., Fang, F., Decato, B., Molaro, A., van de Werken, H.J., 
van Es, J.H., Schuijers, J., de Wit, E., de Laat, W., et al. (2013). DNA methylation 
dynamics during intestinal stem cell differentiation reveals enhancers driving gene 
expression in the villus. Genome Biol 14. 
Kang, J., Lienhard, M., Pastor, W.A., Chawla, A., Novotny, M., Tsagaratou, A., Lasken, 
R.S., Thompson, E.C., Surani, M.A., Koralov, S.B., et al. (2015). Simultaneous deletion 
of the methylcytosine oxidases Tet1 and Tet3 increases transcriptome variability in early 
embryogenesis. Proc Natl Acad Sci USA 112, 45. 
	  67	  
Kim, T.-H.H., Escudero, S., and Shivdasani, R.A. (2012). Intact function of Lgr5 
receptor-expressing intestinal stem cells in the absence of Paneth cells. Proc Natl Acad  
Sci USA 109, 3932-3937. 
Kinzel, B., Pikiolek, M., Orsini, V., Sprunger, J., Isken, A., Zietzling, S., Desplanches, 
M., Dubost, V., Breustedt, D., Valdez, R., et al. (2014). Functional roles of Lgr4 and 
Lgr5 in embryonic gut, kidney and skin development in mice. Dev Biol 390, 181-190. 
Kriaucionis, S., and Heintz, N. (2009). The nuclear DNA base 5-hydroxymethylcytosine 
is present in Purkinje neurons and the brain. Science 324, 929-930. 
Langmead, B., Trapnell, C., Pop, M., and Salzberg, S.L. (2008). Ultrafast and memory-
efficient alignment of short DNA sequences to the human genome. Genome Biol 10. 
Li, E., Bestor, T.H., and Jaenisch, R. (1992). Targeted mutation of the DNA 
methyltransferase gene results in embryonic lethality. Cell 69, 915-926. 
Lian, C.G., Xu, Y., Ceol, C., Wu, F., Larson, A., Dresser, K., Xu, W., Tan, L., Hu, Y., 
Zhan, Q., et al. (2012). Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of 
melanoma. Cell 150, 1135-1146. 
Maiti, A., and Drohat, A.C. (2011). Thymine DNA glycosylase can rapidly excise 5-
formylcytosine and 5-carboxylcytosine potential implications for active demethylation of 
CpG sites. J Biol Chem. 
Mustata, R.C., Vasile, G., Fernandez-Vallone, V., Strollo, S., Lefort, A., Libert, F., 
Monteyne, D., Pérez-Morga, D., Vassart, G., and Garcia, M.-I. (2013). Identification of 
Lgr5-Independent Spheroid-Generating Progenitors of the Mouse Fetal Intestinal 
Epithelium. Cell Reports 5. 
Okano, M., Bell, D.W., Haber, D.A., and Li, E. (1999). DNA methyltransferases Dnmt3a 
and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 
247-257. 
Pastor, W.A., Pape, U.J., Huang, Y., Henderson, H.R., Lister, R., Ko, M., McLoughlin, 
E.M., Brudno, Y., Mahapatra, S., Kapranov, P., et al. (2011). Genome-wide mapping of 
5-hydroxymethylcytosine in embryonic stem cells. Nature 473, 394-397. 
	  68	  
Rao, J.N., and Wang, J.-Y.Y. (2010). Regulation of Gastrointestinal Mucosal Growth. 
Morgan & Claypool Life Sciences. 
Reik, W., Dean, W., and Walter, J. (2001). Epigenetic reprogramming in mammalian 
development. Science 293, 1089-1093. 
Rudenko, A., Dawlaty, M.M., Seo, J., Cheng, A.W., Meng, J., Le, T., Faull, K.F., 
Jaenisch, R., and Tsai, L.-H.H. (2013). Tet1 is critical for neuronal activity-regulated 
gene expression and memory extinction. Neuron 79, 1109-1122. 
Sato, T., Vries, R.G., Snippert, H.J., van de Wetering, M., Barker, N., Stange, D.E., van 
Es, J.H., Abo, A., Kujala, P., Peters, P.J., et al. (2009). Single Lgr5 stem cells build crypt-
villus structures in vitro without a mesenchymal niche. Nature 459, 262-265. 
Sheaffer, K.L., Kim, R., Aoki, R., Elliott, E.N., Schug, J., Burger, L., Schübeler, D., and 
Kaestner, K.H. (2014). DNA methylation is required for the control of stem cell 
differentiation in the small intestine. Genes Dev 28, 652-664. 
Smith, Z.D., and Meissner, A. (2013). DNA methylation: roles in mammalian 
development. Nat Rev Genet 14, 204-220. 
Tahiliani, M., Koh, K.P., Shen, Y., Pastor, W.A., Bandukwala, H., Brudno, Y., Agarwal, 
S., Iyer, L.M., Liu, D.R., Aravind, L., et al. (2009). Conversion of 5-methylcytosine to 5-
hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-
935. 
Weber, A.R., Krawczyk, C., Robertson, A.B., Kuśnierczyk, A., Vågbø, C.B., 
Schuermann, D., Klungland, A., and Schär, P. (2016). Biochemical reconstitution of 
TET1-TDG-BER-dependent active DNA demethylation reveals a highly coordinated 
mechanism. Nat Commun 7, 10806. 
Wu, H., D'Alessio, A.C., Ito, S., Wang, Z., Cui, K., Zhao, K., Sun, Y.E., and Zhang, Y. 
(2011). Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual 
function in transcriptional regulation in mouse embryonic stem cells. Genes Dev 25, 679-
684. 
Xin, Y.-J.J., Yuan, B., Yu, B., Wang, Y.-Q.Q., Wu, J.-J.J., Zhou, W.-H.H., and Qiu, Z. 
(2015). Tet1-mediated DNA demethylation regulates neuronal cell death induced by 
oxidative stress. Scientific reports 5, 7645. 
	  69	  
Yamaguchi, S., Hong, K., Liu, R., Shen, L., Inoue, A., Diep, D., Zhang, K., and Zhang, 
Y. (2012). Tet1 controls meiosis by regulating meiotic gene expression. Nature 492, 443-
447. 
Yu, D.-H.H., Gadkari, M., Zhou, Q., Yu, S., Gao, N., Guan, Y., Schady, D., Roshan, 
T.N., Chen, M.-H.H., Laritsky, E., et al. (2015). Postnatal epigenetic regulation of 
intestinal stem cells requires DNA methylation and is guided by the microbiome. 
Genome Biol 16, 211. 
Zhang, R.-R.R., Cui, Q.-Y.Y., Murai, K., Lim, Y.C., Smith, Z.D., Jin, S., Ye, P., Rosa, 
L., Lee, Y.K., Wu, H.-P.P., et al. (2013). Tet1 regulates adult hippocampal neurogenesis 
and cognition. Cell stem cell 13, 237-245. 
 
	  
	  70	  
CHAPTER 3 
 
 
 
5-hydroxymethylcytosine represses the activity of enhancers in embryonic stem 
cells: a new epigenetic signature for gene regulation 
 
 
I. Choi*, R. Kim*, H.-W. Lim, K.H. Kaestner+, K.-J. Won+. 
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3.1 Summary 
	  
Recent mapping of 5-hydroxymethylcytosine (5hmC) provides a genome-wide 
view of the distribution of this important chromatin mark. However, the role of 5hmC in 
specific regulatory regions is not clear, especially at enhancers. We found a group of 
distal transcription factor binding sites highly enriched for 5-hydroxymethylcytosine 
(5hmC), but lacking any known activating histone marks and being depleted for nascent 
transcripts, suggesting a repressive role for 5hmC in mouse embryonic stem cells 
(mESCs). 5-formylcytosine (5fC), which is known to mark poised enhancers where 
H3K4me1 is enriched, is also observed at these sites. Furthermore, the 5hmC levels were 
inversely correlated with RNA polymerase II (PolII) occupancy in mESCs as well as in 
fully differentiated adipocytes. Interestingly, activating H3K4me1/2 histone marks were 
enriched at these sites when the associated genes become activated following lineage 
specification. These putative enhancers were shown to be functional in embryonic stem 
cells when unmethylated. Together, these data suggest that 5hmC suppresses the activity 
of this group of enhancers, which we termed “silenced enhancers”. Our findings indicate 
that 5hmC has a repressive role at specific proximal and distal regulatory regions in 
mESCs, and suggest that 5hmC is a new epigenetic mark for silenced enhancers. 
 
Keywords 
5hmC, GROseq, PolII, eRNA, mESC, Enhancer	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3.2 Background 
	  
5-hydroxymethylcytosine (5hmC) is an epigenetic mark that arises from oxidation 
of 5-methylcytosine (5mC) by Ten-eleven translocation (Tet) enzymes(Tahiliani et al., 
2009; Williams et al., 2011). The 5hmC mark has been studied in several cell types, such 
as mouse embryonic stem cells (mESCs) (Tahiliani et al., 2009; Yu et al., 2012), 
neuronal cells (Kriaucionis and Heintz, 2009; Mellen et al., 2012; Szulwach et al., 2011) 
and adipocytes (Serandour et al., 2012). 5hmC is enriched at promoters marked 
bivalently by H3K4me3 and H3K27me3 in mESCs (Matarese, 2011), but depleted at 
promoters in the brain (Szulwach et al., 2011). 5hmC is also enriched at specific 
transcription factor binding sites (TFBSs) in human and mouse ESCs (Ficz et al., 2011; 
Pastor et al., 2011; Stroud et al., 2011; Szulwach et al., 2011; Williams et al., 2011; Wu 
et al., 2011; Xu et al., 2011). Specifically, in mESCs, 5hmC is depleted at Sox2 and Oct4 
binding sites, but enriched for Esrrb and Tcfcp2l1 occupancy (Wu et al., 2011). In human 
embryonic stem cells (hESCs), 5hmC is highly enriched at CTCF, Nanog, and Oct4 
binding sites (Stroud et al., 2011). Another study in hESC observed that the 5hmC profile 
showed a bimodal distribution at Oct4, Sox2, TAF1 and p300 binding sites (Szulwach et 
al., 2011). While these studies suggest a possible regulatory role for 5hmC at promoters 
and TFBSs, its function at these regulatory regions remains unclear. 
Here, we report on a new repressive role for 5hmC at specific regulatory regions 
in mESCs. We show that 5hmC negatively correlates with nascent transcripts, especially 
at TFBSs. Interestingly, we discovered that a group of distal TFBSs displays a new 
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epigenetic signature; these sites are exclusively enriched for 5hmC, depleted for 
activating histone modification marks (H3K4me1 and H3K27ac), and significantly 
reduced for nascent transcripts or enhancer RNAs (eRNAs). The expression of the genes 
close to these TFBSs was significantly lower than that of genes close to other classes of 
TFBSs. In addition, we found that a fraction of these TFBSs becomes enriched for 
activating histone marks (H3K4me1/2) in neural progenitor cells (NPCs) or 
endomesoderm cells. RNA polymerase II (PolII) chromatin interaction analysis with 
paired-end tagging (ChIA-PET) (Zhang et al., 2013) showed that the target genes of these 
regulatory regions were indeed significantly upregulated in NPCs. Enhancer/luciferase 
reporter assays demonstrated that these regions function as in gene activation when 5hmC 
is removed for these sites. Together, our findings suggest that 5hmC is as a novel marker 
for transcriptional silent enhancers in mESCs for regulatory regions that are activated 
during development. 
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3.3 Methods 
 
Experimental procedures 
We used genome-wide GROseq maps (Min et al., 2011) and ChIP-seq data for 
chromatin status (Meissner et al., 2008; Mikkelsen et al., 2007), PolII occupancy 
(Mikkelsen et al., 2007), 5mC (Ficz et al., 2011), and Tet1 occupancy (Ficz et al., 2011) 
in mESCs for our integrated analysis. We employed H3K4me1/2 data from NPC 
(Mikkelsen et al., 2007) and endomesoderm cells (Yu et al., 2013) to analyze the fate of 
our novel 5hmC regions after differentiation. We also included 5hmC from various 
independent studies (Pastor et al., 2011; Tan et al., 2013; Williams et al., 2011; Wu et al., 
2011; Wu and Zhang, 2011; Xu et al., 2011) for our analysis. Table 3.1 summarizes all 
genome-wide datasets we used in our study. 
All ChIP-seq data were normalized to 10 reads per kilobase per million mapped 
reads (RPKM) (Mortazavi et al., 2008). For clustering analysis we used Mev V4.8 (Saeed 
et al., 2006) and applied the K-means clustering algorithm using the Pearson correlation 
with absolute distance as a metric. To cluster distal TFBs in mESCs, we used the 
H3K4me1/2/3, H3K27ac, H3K27me and 5hmC levels and generated applied clustering 
(K  =  10). We showed other epigenetic marks and GROseq and PolII next to the identified 
clusters. 
To study the functional roles of 5hmC in various regulatory regions, we employed 
binding site data of 13 TFs (Nanog, Oct4, STAT3, Smad1, Sox2, Zfx, c-Myc, n-Myc, 
Klf4, Esrrb, Tcfcp2l1, E2f1 and CTCF) in mESC (Chen et al., 2008). 
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To investigate 5hmC and nascent RNA levels across genes, we divided the genes 
into promoter (from -1Kbp to 500 bp around the annotated start site), 3′ end (from 
−500 bp to 500 bp around the annotated termination site), and gene body regions (500 bp 
from the annotated start site to −500 bp from the annotated termination site). For 
transcription levels, we calculated RPKM using GROseq reads from 500 bp of the 
annotated start site to the annotated termination site in order not to include transcriptional 
pausing at promoters (Core et al., 2008; Rahl et al., 2010). 
 
Luciferase reporter assay 
Genomic DNA was prepared from R1 mouse embryonic stem cells(Nagy et al., 
1993). About 600 bp genomic fragments for five distal TFBSs in cluster 2 were amplified 
by PCR with dNTPs and the PCR products ligated into the pGL3-SV40 luciferase vector 
(Promega). Empty vector (control) or cloned vectors were transfected directly into R1 
mESC, together with the pRL-tk vector (Promega) as internal control, using 
Lipofectamine LTX (Life Technologies). At 24 h after transfection, cells were harvested 
and lysates subjected to the dual-luciferase reporter assay (Promega). Firefly luciferase 
activity was measured and normalized to the internal control, Renilla luciferase activity. 
 
Table 3.1.  Datasets. 
Cell type Data type GEO accession number  Reference 
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mESCs (E14) 
ChIP-seq (Nanog, Oct4, 
STAT3, Smad1, Sox2, Zfx, c-
Myc, n-Myc, Klf4, Esrrb, 
Tcfcp2l1, E2f1 and CTCF) 
GSE11431 (Chen et al., 2008) 
mESCs (E14) MeDIP-seq : 5mC ChIP-seq : H3K27ac 
GSE38596 
GSE36114 
(Yu et al., 
2012) 
(Xiao et al., 
2012) 
mESC (E14) 
NSC, NPC ChIA-PET GSE44067 
(Zhang et al., 
2013) 
mESC(E14)-
Endomesoderm 
ChIP-seq : H3K4me1, 
H3K4me2 
GSE36114 
GSE38596 
(Xiao et al., 
2012) 
 
mESCs( E14TG2a.4) 5hmC (Williams) GSE24841 (Williams et al., 2011) 
mESCs(E14Tg2A) Bisulfite-seq : 5hmC GSE36173 (Yu et al., 2012) 
mESCs(J1/E14) TET1,MeDIP-Seq: 5hmC GSE28500 (Cortellino et al., 2011) 
mESCs (J1) MeDIP-Seq: 5mC, 5hmC EBI: EPR000570 (Cortellino et al., 2011) 
mESCs (V6.5) GROseq GSE27037 (Min et al., 2011) 
mESCs (V6.5) 
ChIP-seq : H3K4me1, 
H3K4me2,  H3K4me3, 
H3K27me3, PolII 
GSE11172 
GSE12241 
(Meissner et 
al., 2008; 
Mikkelsen et 
al., 2007) 
mESCs (V6.5) 5hmC(Pastor)-GLIB 5hmC(Pastor)-CMS GSE28682 
(Pastor et al., 
2011) 
mESCs(V6.5) RNA-seq : Tet1kd, Tet2kd GSE50198 (Huang et al., 2014) 
mESCs (Tdgfl/fl) 5fC GSE41545 (Song et al., 2013) 
mESCs(46C) MeDIP-Seq : 5hmC (Tan) GSE40810 (Tan et al., 2013) 
mNPCs MeDIP-Seq : 5hmC (Tan) GSE40810 (Tan et al., 2013) 
  Mouse adipocyte 
(3T3L1) 
ChIP-seq : PPARγ, PolII GSE13511 (Nielsen et al., 2008) 
hESCs (H1) 
 
Bisulfite-seq : 5hmC GSE36173 (Yu et al., 2012) 
H3K4me1, H3K27ac, DNaseI ENCODE (Bernstein et al., 2010) 
GROseq GSE41009 (Sigova et al., 2013) 
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3.4 Results 
 
A group of 5hmC-enriched distal TFBSs is lacking activating histone marks and 
nascent RNA transcription 
A recent survey had found 5hmC enriched at TFBSs in hESC (Stroud et al., 
2011), mouse neuronal cells, and adipocytes (Serandour et al., 2012). Therefore, we 
investigated 5hmC levels (Xu et al., 2011) at the binding sites of 13 key transcription 
factors (TFs) (Nanog, Oct4, STAT3, Smad1, Sox2, Zfx, c-Myc, n-Myc, Klf4, Esrrb, 
Tcfcp2l1, E2f1 and CTCF) in mESC (Chen et al., 2008). We confirmed previous results 
(Stroud et al., 2011; Wu et al., 2011) that 5hmC was generally depleted at the core of the 
proximal (within 2 kb to transcription start sites (TSSs)) TFBSs, but relatively high in the 
regions neighboring (±2 kb) the core (Figure 3.1A). We also confirmed that 5hmC is 
highly enriched at the core of distal binding sites of many TFs, such as Zfx and Esrrb 
(Figure 3.1B; (Stroud et al., 2011; Wu et al., 2011)). 
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Figure 3.1 5hmC profile at promoters and enhancers. (A) The average profiles of 
5hmC at promoter-proximal TFBSs. 0 represent the center of the TFBSs. (B) The average 
profile of 5hmC at 13 TFBSs in promoter-distal (>2kbps) regions.  
 
To further investigate the role of 5hmC in gene regulation in conjunction with 
other epigenetic marks, we performed an integrative analysis using 5hmC, 5mC (Xu et 
al., 2011), Tet1 (Ficz et al., 2011), H3K4me1/2/3, H3K27me3, RNA polymerase (Pol) II 
occupancy (Mikkelsen et al., 2007) and nascent RNAs from global run-on sequencing 
(GROseq) (Min et al., 2011)data. We found that 5hmC levels were inversely correlated 
with nascent RNA transcription and Pol II occupancy at proximal TFBSs (Figure 3.2). 
We confirmed the levels of 5hmC positively correlated with the levels of the repressive 
H3K27me3 histone mark at proximal TFBSs (Matarese, 2011; Wu et al., 2011). 
 
Figure 3.2 5hmC and other epigenetic modifications in ESCs. (A) Correlation 
between 5hmC and various marks. The TFBSs were sorted based on the 5hmC levels in 
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±2 K regions relative to the center of the binding sites. 5hmC levels at promoter-proximal 
TFBSs were positively correlated with H327me3 levels and inversely correlated with 
GROseq and PolII levels. Transcription levels of the genes associated with the promoter 
were calculated using GROseq . In the sorted list, we averaged the transcription levels of 
the adjacent 100 genes. (B) Clustering results of 5hmC with other epigenomic data at 
distal (>2kbp from known TSSs) TFBSs. Cluster 1, 8 and 10 are enriched for H3K4me3 
and GROseq, showing the properties of promoters. Cluster 5 and 9 display high levels of 
H3K27ac, indicative of active enhancers. Cluster 2 is enriched for 5hmC and 5fC, has 
very low GROseq levels, and lacks all investigated histone marks. 
 
To study the epigenetic landscapes surrounding distal TFBSs, we applied the K-
means algorithm (K  =  10) and found clusters marked by various epigenetic modifications 
(Figure 3.2B). Clusters 1, 8 and 10 showed the properties of active promoters: 
H3K4me2/3 enrichment with relatively low levels of H3K4me1 and the presence of 
nascent RNA transcripts. These clusters thus likely represent the promoters of long 
intergenic non-coding RNAs (Guttman et al., 2009) or un-annotated promoters of 
protein-coding genes. Clusters 5 and 9 showed H3K4me1 and H3K27ac enrichment, 
indicating active enhancers. These clusters, as well as clusters 3, 4, 6, and 7, showed only 
a small amount of nascent transcripts or enhancer RNAs (eRNAs), which have been 
known to correlate with the gene transcription levels of adjacent genes (Core et al., 2008; 
Wang et al., 2011). The presence of eRNAs in these clusters suggest that the TFBS at 
these clusters have an activating role. 
We were especially interested in cluster 2, which was enriched for 5hmC, but was 
depleted of eRNAs. Strikingly, this cluster had no activating histone marks such as 
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H3K4me1 or H3K27ac (Creyghton et al., 2010; Heintzman et al., 2007; Rada-Iglesias et 
al., 2011), even though TFs bind at these sites (Figure3.2B and Figure 3.3). 5mC was 
depleted at the core of the TFBS, consistent with the previous observation in hESCs 
(Lister et al., 2009). Compared with other clusters, cluster 2 was characterized by low 
levels of eRNAs and low PolII occupancy. To confirm the enrichment for 5hmC, we 
investigated the profile of sequencing data from other independent studies (Pastor et al., 
2011; Tan et al., 2013; Williams et al., 2011; Wu et al., 2011; Wu and Zhang, 2011; Xu 
et al., 2011). Cluster 2 was enriched for 5hmC consistently for all four independently 
measured datasets (Figure 3.4). We also examined TAB-seq, which provides base-
resolution sequencing of 5hmC in mESC (Yu et al., 2012). The TAB-seq profile also 
confirmed enrichment for 5hmC at the core of TFBSs for cluster 2 regions for both 
strands (Figure 3.5). Together, these data suggest that 5hmC combined with absence of 
H3K4me1 at distal TFBSs marks inactive enhancers. 
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Figure 3.3 Comparison of the characteristics of each cluster. We plotted the levels of 
H3K4me1/2/3, H3K27ac, H3K27me3, 5mC, 5hmC, GROseq, PolII and 5fC for all 
clusters. Cluster2 is significantly enriched with 5hmC and 5fC, but depleted for enhancer 
marks (H3K4me1/2, H3K27ac), eRNA (GROseq) and PolII. The high level of 5mC is 
due to the enrichment for 5mC at the regions flanking the TFBSs. 
 
 
Figure 3.4 Comparison of the 5hmC patterns for each cluster. 5hmC data were 
obtained from (Pastor et al., 2011; Tan et al., 2013; Williams et al., 2011; Wu et al., 
2011; Wu and Zhang, 2011; Xu et al., 2011). Cluster 2 shows consistent enrichment of 
5hmC for all four independent studies.  
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Figure 3.5 The 5hmC profile of cluster 2 using TAB-Seq. The average profiles of 
5hmC were generated using TAB-Seq data in mESC. 5hmC is enriched at the center of 
TFBSs for both strands.  
 
Surprisingly, cluster 2 is also highly enriched for 5-formylcytosine (5fC) 
compared with other clusters (Figure 3.2B). Both 5fC and 5hmC are involved in the 
active demethylation pathway (Ito et al., 2011; Maiti and Drohat, 2011). Previous 
genome-wide study using 5fC revealed that 5fC is enriched at enhancers, especially at 
poised enhancers marked by H3K4me1 without H3K27ac (Song et al., 2013). However, 
the properties of the cluster 2 regions are novel, as they lack the H3K4me1 mark. This 
strongly suggests that 5hmC as well as 5fC mark a novel type of “poised” or silenced 
enhancer at distal regulatory regions where active histone modification marks are absent. 
Next, we interrogated the state of the 5hmC mark in other cell types. In hESCs, 
we also identified a cluster enriched for 5hmC (Yu et al., 2012) but depleted for both 
H3K4me1 and H3K27ac at distal DNaseI hypersensitive sites (DHSs) (Figure 3.6; 
(Bernstein et al., 2010)). As in mESCs, GROseq levels in hESCs (Sigova et al., 2013) 
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were significantly weaker in this cluster (p-value  =  1.7e-14). In mature adipocytes, we 
observed 5hmC (Serandour et al., 2012) enriched at over 20% of PPARγ binding sites 
(Figure 3.7;(Nielsen et al., 2008)). Surprisingly, PolII occupancy (Nielsen et al., 2008) 
was depleted when 5hmC was enriched (Figure 3.7). These data indicate that 5hmC can 
be a repressive mark at distal regulatory regions regardless of cell type or differentiation 
state. 
 
Figure 3.6 The 5hmC clusters in hESCs. We performed clustering using 5hmC (Yu et 
al., 2012), H3K4me1 and H3K27ac at distal DHSs in hESCs (Bernstein et al., 2010) and 
identified 2 groups. Among 72,395 distal DHSs, we identified 8,034 sites (Group 1) 
enriched for 5hmC, while H3K4me1 and H3K27ac were depleted. GROseq levels 
(Sigova et al., 2013) were significantly weak in this cluster. 
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Figure 3.7 The 5hmC clusters in mature adipocytes. We clustered 5hmC (Serandour et 
al., 2012) with PolII (Nielsen et al., 2008) using the K-means clustering (K=4) algorithm 
at distal PPARγ binding sites (Nielsen et al., 2008). 5hmC and PolII were exclusively 
observed at these enhancers.   
 
Table 3.2 lists the number of binding sites for each TF in cluster 2 in mESCs. The 
majority of the cluster 2 regions were bound by CTCF, Tcfcp2l1 or Esrrb. Fewer binding 
sites for Oct4, Sox2, and Nanog, the master regulators for self-renewal and pluripotency 
in ESCs, were observed in cluster 2 (Boyer et al., 2005). This is consistent with the 
observation that 5hmC is depleted at highly active enhancers in ESCs. We further 
investigated if ChIP intensity is lower for the TFBSs in cluster 2. We did not find 
statistical differences, even though the average profiles of the TFBSs in cluster 2 were 
slightly lower compared with the TFBSs in other clusters (Figure 3.8). 
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Table 3.2 The frequency of transcription factor occupancy in cluster 2.  
Hyper-geometric p-values were calculated. 
 Number of TFBSs in 
cluster 2 
Total number of distal 
TFBSs in mESCs 
Ratio p-value 
CTCF 2,728 27,051 10.08% <1e-130 
E2f1 73 9,730 0.75% 1 
Esrrb 1,004 14,102 7.12% 4e-24 
Klf4 108 5,752 1.88% 1 
cMyc 5 861 0.58% 1 
nMyc 24 2,158 1.11% 1 
Nanog 128 8,912 1.44% 1 
Oct4 33 2,674 1.23% 1 
Sox2 29 3,919 0.74% 1 
Smad1 2 1,032 0.19% 1 
STAT3 33 1,867 1.77% 1 
Tcfcp2l1 1,026 17,881 5.73% 0.0017 
Zfx 85 3,881 2.19% 1 
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Figure 3.8 The average profiles of TFs at cluster 2. The average profiles of 13 TFs in 
cluster 2 and other clusters. The p-value from t-test was calculated using the signals 
around ±100bps. The significant p-values for Smad1 is because of the low number (2) of 
binding sites and for E2f1 the flanking signals around the binding sites. 
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5hmC-enriched distal TFBSs are associated with developmental genes 
Next, we analyzed the correlation between 5hmC levels and transcriptional 
activity of the genes closest to the TFBSs for each cluster. To calculate gene transcription 
levels, we calculated the reads per kilobase per million mapped reads (RPKM) from 
GROseq (see Methods). The genes mapping to the TFBSs in cluster 2 had strikingly 
reduced transcription levels compared to the genes in all other clusters (p-value <1.3e-
20), even compared to clusters 8 and 10, where the repressive H3K27me3 mark was 
relatively enriched (Figure 3.9A). GO analysis of the genes closest to the TFBSs in 
cluster 2 using GREAT (McLean et al., 2010) revealed that the genes in this cluster were 
enriched for developmental functions, such as “muscle cell development” (p-
value  =  3.4e-14)” and “foregut morphogenesis” (p-value  =  5.8e-9) (Figure 3.9B). This is 
consistent with the fact that these genes are silent in ESCs and are only activated once 
differentiation commences. 
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Figure 3.9 Functional analysis for TFBSs with 5hmC. (A) Comparison of the 
transcription levels of the nearest genes between cluster 2 and the other 9 clusters of 
distal TFBSs identified in Figure 3.2B. The transcription levels (RPKM) were calculated 
using GROseq data. (B) GO analysis for the genes close to TFBSs in cluster 2. Organ 
development terms are enriched. 
 
A snapshot in Figure 3.10 shows the enrichment for 5hmC at the Klf4 and the 
Esrrb binding sites located in the first intron of Sorcs2. Sorcs2 is highly expressed in the 
developing and mature murine central nervous system (Rezgaoui et al., 2001). We 
observed that Sorcs2 is silent in mESC, and its promoter is bivalently marked by 
H3K4me3 and H3K27me3 (Mikkelsen et al., 2007). In mouse neural progenitor cells 
(NPCs), however, Sorcs2 is highly expressed (Mikkelsen et al., 2007). The Klf4 and the 
Esrrb binding sites are marked by H3K4me1 in NPCs, suggesting an active role of this 
region as an enhancer during neural development. 
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Figure 3.10 Chromatin organization at the Sorcs2 gene in mESCs. The Klf4 and the 
Esrrb binding sites in the intron of Sorcs2 gene are enriched for 5hmC. These binding 
sites are depleted with H3K4me1 in mESCs, but are enriched in NPCs. 
 
5hmC-enriched distal TFBSs become activated during development in a lineage-
specific way 
Because of the coordination of high 5hmC levels with low expression of genes in 
cluster 2, we hypothesized that 5hmC may attenuate enhancer activity in mESCs, which 
becomes activated later during development. Therefore, we analyzed H3K4me1/2 data in 
NPCs (Mikkelsen et al., 2007) and endomesoderm cells (Yu et al., 2013). H3K4me1 and 
H3K4me2 are known to mark enhancers (Heintzman et al., 2007). While H3K4me1/2 
enhancer marks were depleted in mESCs, around 9% of distal TFBSs (out of 5,278 
TFBSs) showed enriched H3K4me1/2 occupancy in NPCs, and an additional 20% of 
TFBSs were enriched for H3K4me1/2 in endomesoderm cells (Figure 3.11). Overall, 
5hmC levels were significantly decreased in cluster 2 regions after differentiation into 
NPCs (Tan et al., 2013). This finding suggests that a group of 5hmC-enriched enhancers 
are repressed in mESCs, but selectively become activated during development towards 
the neuronal or endomesoderm lineage. This implies that other regions in cluster 2 might 
be activated when ESCs are differentiated into other lineages such as primordial germ 
cells. 
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Figure 3.11 Lineage specific activation of distal TFBSs in cluster 2. (A) The enriched 
H3K4me1/2 in NPCs or endomesoderm cells suggests the potential lineage specific 
enhancer activation of the TFBSs in cluster 2 after differentiation. (B) The target genes of 
cluster 2 in NPCs identified using ChIA-PET become significantly upregulated (p-value: 
0.04) when they gained interactions. The expression change in MEF is compared as a 
control (p-value: 0.12). 
 
To further determine if the TFBSs in cluster 2 have activating roles in a lineage-
specific way, we used chromatin connectivity maps from chromatin interaction analysis 
with paired-end tagging (ChIA-PET) associated with PolII in ESCs and NPCs (Zhang et 
al., 2013). By using the chromatin interaction information, we mapped the target genes of 
the TFBSs in cluster 2 that were only selectively activated in NPCs. The target genes in 
ESCs were slightly downregulated in NPC (as well as in mouse embryo fibroblasts 
(MEFs)) because only a small portion of them become activated in a lineage-specific 
manner as shown in Figure 3.11A. In contrast, the target genes in NPCs become 
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significantly upregulated during the transition from ESCs to NPCs (p-value <0.05). 
Moreover, the changes were significant compared with the target genes for clusters (all p-
values were <0.02) (Figure 3.12). This further supports the notion that TFBSs in cluster 2 
become activated in a lineage specific way following embryonic stem cell differentiation. 
Figure 3.12 The gene expression change for the target genes for each cluster. Using 
ChIA-PET, we obtained the target genes in ESCs and in NPCs. The genes with 
interacting chromatin in ESCs overall down-regulated. The target genes of cluster 2 
significantly upregulated compared with other clusters (all p-values<0.02). (* if p-
value<0.001 and ** if p-value <0.0001) 
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Cluster 2 regions show enhancer activity in mESCs when devoid of 5hmC 
Next, we directly determined if lack of 5hmC activates enhancer activity of the 
distal TFBSs in mESCs. We selected five highly 5-hydroxymethylated distal TFBSs 
regions from cluster 2, including the site in Sorcs2 (TFBS1). This site is also enriched for 
ChIA-PET (Zhang et al., 2013) reads. We amplified these sequences (±600 bp) by PCR 
and subcloned them into luciferase reporter plasmids containing a minimal promoter. We 
found that these DNA sequences indeed possess enhancer activity in mESCs when 
lacking 5hmC, showing on average 3-fold increased luciferase activity compared to 
control (Figure 3.13). This in vitro study suggests that 5hmC-enriched distal TFBSs are 
bona fide enhancers, which are silent in mESCs when marked with 5hmC. 
 
Figure 3.13 Enhancer activity of distal TFBSs lacking 5hmC in mESCs. 
(A) Schematic diagram of the experimental setup. (B) Luciferase reporter assay for 
5hmC-enriched putative enhancer regions (about 600 bp) including distal TFBSs in 
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mESCs. Control: empty vector, TFBS1: 5hmC-enriched Klf4/Esrrb binding site (Figure 
3.10), TFBS2: 5hmC-enriched Esrrb/Tcfcp2I1 binding site, TFBS3: 5hmC-enriched 
Tcfcp2I1 binding site, TFBS4: 5hmC-enriched E2f1 binding site, TFBS5: 5hmC-
enriched Nanog/Sox2. The normalized luciferase activity of control is set as 1. *p-
value  <  0.05. 
 
We also investigated if 5hmC at distal regulatory regions has a repressive role 
using the Tet1 shRNA suppression experiments in mESCs (Huang et al., 2014). We 
found that the target genes of cluster 2 were significantly upregulated (p-value  <  0.01) 
after Tet1 gene suppression, suggestive of repressive roles of 5hmC (Figure 3.14). We 
did not find a similar pattern in Tet2 shRNA-treated mESCs, possibly due to the fact that 
Tet2 is dominantly associated with the 5hmC present in gene bodies (Huang et al., 2014). 
 
Figure 3.14 The gene expression changes of the target genes after Tet1 knockdown 
for each cluster. Fold changes were calculated using RNAseq data after Tet1 
knockdown in mESCs (Huang et al., 2014). After knockdown of Tet1, the changes were 
significant in cluster 2 (p-value: 0.006). For other clusters, p-value>0.01.  
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Figure 3.15 The 5hmC in mESC and NPC at the TFBSs in mESCs. TFBS from all 
clusters (except for cluster 2) were sorted based on the 5hmC levels in NPC. We used 
5hmC in mESCs and NPC from (Tan et al., 2013). 
 
	  
Figure 3.16 5hmC at CTCF binding sites in cluster 2. 5hmC levels were shown at the 
CTCF binding sites in cluster 2. After differentiation into NPCs, 5hmC become depleted. 
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3.5 Discussion 
 
The field of DNA methylation has expanded recently, with the identification of 
multiple cytosine variants; 5hmC, 5fC, and 5-carboxylcytosine (5-caC) (He et al., 2011; 
Ito et al., 2011). Among the cytosine variants, 5hmC has been most extensively studies 
(Ficz et al., 2011; Pastor et al., 2011; Stroud et al., 2011; Szulwach et al., 2011; Williams 
et al., 2011; Wu et al., 2011; Xu et al., 2011; Yu et al., 2012). Although there are 
genome-wide 5hmC maps in several cell types, our understanding about the functional 
role of 5hmC remains limited. 
The contribution of the 5hmC modification to gene regulation is actively debated. 
Recent studies found that 5hmC gain is accompanied by H3K27me3 loss at promoters 
and in the gene body during neurogenesis, suggesting an activating role of 5hmC (Hahn 
et al., 2013). On the other hand, the presence of 5hmC at the promoter of bivalently 
marked genes (Matarese, 2011; Pastor et al., 2011; Wu et al., 2011) and in 
vitro transcription studies revealed a repressive role of 5hmC at promoter regions 
(Robertson et al., 2011). However, the role of 5hmC at enhancers has not been 
investigated thus far. 
We observed that enrichment of 5hmC corresponds with the depletion of eRNAs 
at distal TFBSs. Considering that eRNAs correlate with gene transcription (Core et al., 
2008; Wang et al., 2011), we suggest that low levels of 5hmC at enhancers are required 
for gene expression. Importantly, we found that a subset of distal TFBSs that carry the 
5hmC mark in embryonic stem cells become enriched for the activating histone mark 
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(H3K4me1/2) following differentiation into neural progenitors or endomesoderm, 
suggesting that distal TFBSs with 5hmC are repressed in mESC but become active 
enhancers in a lineage-specific manner. Indeed, using ChIA-PET interaction information 
(Zhang et al., 2013), we found that those regions that gained connections to their target 
genes were significantly upregulated during differentiation compared with the target 
genes in other clusters. This finding suggests that their target genes were repressed in 
ESCs and become selectively activated in a lineage-specific way. 
To ascertain if the proposed “silent enhancers” identified above can indeed 
function as enhancers we employed luciferase reporter assays. We demonstrated that the 
novel distal elements, characterized by TF binding, high levels of 5hmC, and absence of 
the H3K4me1 “enhancer” mark, can indeed function as enhancers in mESCs if they are 
devoid of the 5hmC modification. This experiment is consistent with the notion that 
5hmC could inhibit enhancer activity at a subset of distal TFBSs in mESCs. 
Our findings are different from the work of Sérandour and colleagues (Serandour 
et al., 2012), who had suggested an activating role for 5hmC at distal regulatory regions. 
They identified 5hmC peaks after differentiation, which were surrounded by the 
activating H3K4me2 mark. However, more than 50% the 5hmC peaks they identified 
were located at genic regions, where they are known to be associated with gene activation 
(Ficz et al., 2011; Hahn et al., 2013; Huang et al., 2014; Kim et al., 2014; Wu et al., 
2011). It is also possible that the 5hmC peaks at distal regions are associated with non-
coding RNAs such as long non-coding RNAs (lincRNAs) (Guttman et al., 2010). 
Sérandour and colleagues also identified 5hmC at distal PPARγ binding sites (Nielsen et 
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al., 2008). Even though Sérandour and colleagues proposed an activating role of 5hmC at 
these master regulator in adipocytes, only a portion of PPARγ binding sites were enriched 
for 5hmC (Serandour et al., 2012). We revisited their data and found that 5hmC was only 
present at sited lacking PolII occupancy (Figure 3.7), indicating that 5hmC at PPARγ 
binding sites bears repressive roles in mature adipocytes. 
In hESCs, we also identified a group of distal DHSs with strong 5hmC but weak 
H3K4me1 and H3K27ac (Figure 3.6). The GROseq levels were significantly weak for the 
group with 5hmC (Figure 3.6). These lines of evidences suggest a general repressive role 
of 5hmC at distal regulatory regions. 
In ESCs, poised enhancers have been suggested to exist at sites where both 
activating marks (H3K4me1) and repressive marks (H3K27me3) are enriched, but 
H3K27ac is depleted (Creyghton et al., 2010; Rada-Iglesias et al., 2011). 5fC is enriched 
in this type of poised enhancers (H3K4me1[+] and H3K27ac[−]) (Song et al., 2013). In 
contrast to these poised enhancers, we identify a novel group of enhancers with no 
activating histone marks (H3K4me1[−] and H3K27ac[−]) but enrichment only for 5hmC. 
Furthermore, this group is strongly enriched for 5fC, even though cluster 2 lacks the 
H3K4me1 mark (Figure 3.2). Our results strongly suggest that 5hmC and 5fC can be 
epigenetic mark for poised or silent enhancers. As shown in our results, many of these 
enhancers display activating histone marks only after differentiation has occurred (Figure 
3.11). The existence of 5hmC and 5fC also show the active oxidation dynamics at these 
sites. 
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We found that 5hmC was enriched at distal PPARγ binding sites in fully 
differentiated adipocytes. These findings suggest 5hmC as a new marker for poised 
enhancers even in absence of H3K4me1 and H3K27me3. Additionally, we also found 
enriched 5hmC in NPC at the subset of the active TFBSs (except for cluster 2) in mESCs 
(Figure 3.15). This may suggest that active enhancers in mESCs are repressed by 5hmC 
in NPC to remove the enhancer activities in mESCs. 
The majority of cluster 2 regions are CTCF binding sites (Table 3.2). In general, 
5hmC levels negatively correlated with CTCF occupancy in cluster 2 (Figure 3.16). After 
differentiation into NPCs, 5hmC became depleted at these sites even though the binding 
CTCF remained. At these sites, we did not observe activating H3K4me1 and H3K4me2 
marks. However, it is difficult to discuss the role of 5hmCs at these sites, because CTCF 
takes part in various regulatory roles including transcriptional activation, repression, as 
well as the formation of higher order chromatin structure (Nikolaev et al., 2009). The 
function of 5hmC in mESCs at CTCF binding sites warrants further study. 
We report a new repressive role for 5hmC in gene regulatory regions in mESCs. 
The TFBSs enriched for 5hmCs were depleted for nascent transcripts and activating 
histone modification marks in human and mouse ESCs. Furthermore, the 5hmC levels 
were inversely correlated with PolII occupancy in mESCs as well as in fully 
differentiated adipocytes. Our findings indicate that 5hmC has a repressive role at 
specific distal regulatory regions and suggest that 5hmC is a new epigenetic mark for 
silenced enhancers.   
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Conclusions and Future direction 
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4.1 TET1-meditated DNA hydroxymethylation is required for the regulation of gene 
expression in intestinal stem cells. 
	  
5-hydroxymethycytosine (5hmC) is converted from 5-methylcytosine (5mC) by 
Ten-eleven translocation (TET) enzymes, which can further oxidize 5hmC to 5-
formylcytosine and 5-carboxycytosine (Ito et al., 2011; Kriaucionis and Heintz, 2009; 
Tahiliani et al., 2009). These oxidation products are thought to be involved in DNA 
demethylation in mammals (Hashimoto et al., 2012; He et al., 2011; Maiti and Drohat, 
2011; Valinluck and Sowers, 2007). This suggests that 5hmC could be the first step 
towards reversing the repressive effects of 5mC on gene expression (Ficz et al., 2011; 
Nestor et al., 2012). Recently, it has been suggested that TET1 and 5hmC are important 
for gene expression during differentiation of a human colon carcinoma epithelial cell line 
(Chapman et al., 2015).  
In Chapter 2, I investigated the role of 5hmC and TET1 during intestinal stem cell 
(ISC) maturation and differentiation. To determine the genome-wide map of 5hmC, I 
isolated intestinal stem cells and differentiated villus cells from adult mice and performed 
hydroxymethylated DNA immunoprecipitation followed by next-generation sequencing. I 
found that 5hmC is enriched at highly expressed genes such as the Wnt target genes in 
ISCs, and at genes encoding metabolic and transport function in differentiated cells. To 
examine if altered DNA hydroxymethylation leads to intestinal defects, I used Tet1-/- 
mice and found growth retardation and postnatal lethality in the mutant mice. In the Tet1-
deleted postnatal intestine, I observed reduced proliferation, and decreased Wnt target 
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gene expression levels, which correlated with significantly decreased 5hmC levels at the 
relevant promoter regions in Tet1 null mice. This finding suggests that Tet1-mediated 
DNA hydroxymethylation is essential for epigenetic regulation of Wnt target and stem 
cell genes in ISCs.  
Although I showed that reduced expression of several Wnt target genes correlated 
with decreased levels of 5hmC at their promoters in Tet1 null intestinal crypts, in the 
future it would be interesting to determine differential 5hmC levels and gene expression 
changes in the Tet1 null crypt compared to wild-type crypts on genome-wide in an 
unbiased manner using next-generation sequencing. To investigate the details of 5hmC 
dynamics during intestinal epithelial differentiation further, single-base resolution 
mapping of 5hmC in ISCs and differentiated cells would be helpful. We have already 
published single-base resolution map of 5mC in ISCs and differentiated cells (Sheaffer et 
al., 2014), and have started preparing DNA libraries for 5hmC mapping at single-base 
resolution. With both 5mC and 5hmC maps at single-base resolution, we can identify 
DNA methylation and hydroxymethylation levels at each cytosine residue precisely and 
characterize their relationship to gene expression with our existing RNA sequencing data 
(Sheaffer et al., 2014).  
Whereas genome-wide maps for a few transcription factors and histone 
modifications in ISCs and differentiated cells are already available (Kim et al., 2012; San 
Roman et al., 2015; Sheaffer et al., 2014; Verzi et al., 2013), epigenomic information of 
intestinal differentiation and specific cell types is still limited. We have performed 
chromatin-immunoprecipation sequencing for several histone modifications, such as 
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H3K4me1, H3K4me3 and H3K27me3, and defined open chromatin regions using 
transposase-accessible chromatin sequencing (ATAC-seq) in ISCs and differentiated 
cells. With all these datasets, integrative analyses will be required for a comprehensive 
view of epigenomic regulation during intestinal stem cell differentiation. We have 
provided the basis for this integrative analysis, and current and future research is directed 
at this problem.  
We found postnatal lethality and intestinal defects in Tet1-/- mutant mice, which is 
similar to the phenotype seen in mice with conditional deletion of Dnmt1 in the 
developing intestine using Dnmt1f/f; VillinCre mice (Elliott et al., 2015; Yu et al., 2015). 
This suggests DNA methylation and demethylation are both important for intestinal 
maturation in the postnatal period. But, still, the definitive role of Tet1-mediated DNA 
hydroxymethylation in the intestine warrants further investigation using intestinal-
specific gene ablation models. We have begun to derive Tet1-3f/f mice for conditional 
gene deletion in the intestinal epithelium.  
To ascertain the critical role of Tet1 in intestinal stem cells, we could examine if 
regenerative capacity of Tet1-deleted intestine after radiation injury is altered in future 
studies. In the wild-type intestine, intestinal stem cells can repopulate the intestinal 
epithelium and show robust regenerative capacity after damage (Booth and Potten, 2000). 
We have preliminary results that intestinal regenerative capacity of Tet1-deleted mice is 
compromised, which warrants further investigation. 
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4.2 5hmC can function as a repressive mark at distal transcription factor binding 
sites 
	  
5hmC is not just an intermediate product of the DNA demethylation process. It is 
abundant in post-mitotic neuronal cells, and relatively stable showing distinct patterns in 
each tissue of the body (Bachman et al., 2014; Kriaucionis and Heintz, 2009; Li and Liu, 
2011), and have specific binding proteins (“readers”) that regulate gene expression 
(Frauer et al., 2011; Mellén et al., 2012; Spruijt et al., 2013; Yildirim et al., 2011). 
Therefore, 5hmC could function as a new stable or semi-stable epigenetic mark, and not 
just as a kinetic intermediate towards demethylation. 5hmC is also present at bivalent 
promoters of poised developmental genes (Pastor et al., 2011; Wu et al., 2011) and has a 
role in pausing or silencing gene expression (Robertson et al., 2011; Szulwach et al., 
2011). 
 In Chapter 3, we identified putative enhancer sites, which are transcription factor 
binding sites (TFBSs) with high levels of 5hmC and no active histone modifications, in 
mouse embryonic stem cells (ESCs). We performed integrative analyses with genome-
wise sequencing datasets of various epigenetic factors, transcription factors, nascent 
RNAs and RNA Polymerase II in ESCs, and found about distal 5,000 transcription factor 
binding sites as putative enhancer sites fitting these criteria. A subset of them lost 5hmC 
and gained active histone marks during ESC differentiation towards a specific lineage. 
We also determined the enhancer activity of a subset of these elements when they were 
devoid of 5hmC using reporter assays. These findings suggest that 5hmC has a repressive 
role at a subset of distal TFBSs, and marks silenced developmental enhancers in ESCs.  
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 Tet1 and Tet2 are highly expressed in ESCs and are required for ESC 
maintenance and proper differentiation. Depletion of Tet1 and Tet2 in ESCs causes 
spontaneous and/or skewed differentiation. (Ito et al., 2010; Koh et al., 2011). It is 
possible that the silenced developmental enhancers described above could be activated in 
these conditions due to decreased levels of 5hmC in Tet1 and Tet2-deficient ESCs, and 
that this aberrant enhancer activation contributes to the mutant phenotype.  
 To further validate the function of silenced developmental enhancers during ESCs 
differentiation, we could delete them using clustered regularly interspaced short 
palindromic repeats (CRISPR)/CRISPR associated protein system (Cong et al., 2013) in 
ESCs and examine the differentiation capacity of mutant ESCs. With this approach, one 
could determine whether silenced developmental enhancers are actually necessary to be 
activated by loss of 5hmC and the acquisition of active histone modifications.  
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4.3 The dual role of 5hmC in gene activation and repression 
	  
 Targeting the TET1 catalytic domain to specific CpGs in the promoter proximal 
regions for DNA demethylation leads to target gene activation (Maeder et al., 2013). In 
chapter 2, high levels of 5hmC in promoters and gene bodies were correlated with active 
gene expression in intestinal stem and differentiated cells. This suggests that 5hmC is 
involved in DNA demethylation and maintaining an open chromatin structure for active 
transcription. However, it has been also shown that 5hmC is enriched at bivalent 
promoters of poised developmental genes in embryonic stem cells (Pastor et al., 2011; 
Wu et al., 2011). In chapter 3, enrichment of 5hmC suppresses enhancer activity of a 
group of distal transcription factor binding sites, which is associated with poised 
developmental genes in embryonic stem cells. This suggests that 5hmC is not only 
involved in DNA demethylation for gene activation, but can also contribute to gene 
repression as a stable epigenetic modification in bivalent promoters and silent enhancers 
of poised genes in stem cells.  
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